TSS:Rfhg 138644.1

Basic information about the TSS

---

TSS ID: rfhg_138644.1 Species: human Chr: chr11		Start: 64778474 End: 64778486 Strand: -
Source datasets	PRJNA615891|PRJNA4843412|DRA013844
Protocol	SLIC_CAGE|NETCAGE|CAGE
TSS cluster detected*	3

  * The number of TSS cluster called data-sets (maximum 17)

cCREs annotation

---

Description:	-
Category:	-

  * cCREs are candidates for cis regulatory elements generated from the subset of representative DNase hypersensitivity sites supported by either histone modifications or CTCF-binding data. Find more details here.

Gene and protein annotation

---

Nearest transcript id and distance: ENST00000377387.5:5 GeneID: 7536 HGNC/MGI_ID: HGNC:12950 UniProt_ID: Q15637 Nearer transcript ids and distances: BC038446:11 ENST00000482693.1:-18 ENST00000413951.5:-21 ENST00000681407.1:-35 Y08765:40 BC008080:-54 BC008724:-54 ENST00000377390.8:-56 ENST00000633899.1:-56 NM_001378957.1:-56 NM_001378956.1:-56 NM_001178030.2:-56 NM_201997.3:-56 NM_004630.4:-56 NM_201995.3:-56 NM_201998.3:-56 NM_001346363.2:-56 NM_001346364.2:-56 NM_001346410.2:-56 NM_001346409.2:-56 AK299705:-56 AK296237:-56 AB489174:78 EU832634:80 EU832710:80 CU675923:81 KJ892395:81 Y08766:-187 L49345:-244 L49380:-244 BC032676:-248 BC020217:-257 ENST00000227503.13:-261 ENST00000377394.7:-261 ENST00000448404.5:-261 BC069273:-261 ENST00000463343.1:-277 D26120:-277 D26121:-277 BC034451:-283 AK301803:-283 LF211197:-293 MA446774:-293 ENST00000334944.9:-300 ENST00000472725.5:437 view more...

Gene_name: splicing factor 1 Gene_symbol: SF1 Gene_synonyms: ZCCHC25 ZFM1 Gene_source: HGNC:12950

TATA-Box annotation

---

Distance to TSS:	-14
Nearest PromoterID:	NM_001178030
Entrez ID:	7536
Nearest Unigene:	Hs.502829
Nearest Refseq:	NM_004630
Nearest Ensembl:	ENSG00000168066
Gene Name:	splicing factor 1
Gene Alias:	BBP|D11S636|MBBP|ZCCHC25|ZFM1|ZNF162
Gene Type:	protein-coding
CpG%:	0.166667
GC%:	0.692308
TATA-Box(TBP)/Promoter/Homer Distance From Peak(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@SF1 p2@SF1 p3@SF1 p4@SF1 p6@SF1 p10@SF1
Sample		p1@SF1	p2@SF1	p3@SF1	p4@SF1	p6@SF1	p10@SF1
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	82.40	52.79	3.90	2.14	2.53	2.34
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	88.41	55.84	4.65	2.43	2.02	1.42
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	84.30	57.29	5.59	3.09	1.93	2.12
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	79.84	59.25	4.37	2.49	0.42	1.46
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	85.94	60.97	3.60	2.47	1.12	1.35
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	79.07	65.12	4.26	2.13	1.74	1.74
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	116.79	75.39	5.88	2.83	1.96	2.40
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	82.84	64.67	3.15	2.42	2.42	1.70
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	83.99	67.32	4.92	2.78	1.71	1.71
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	89.84	112.45	5.22	2.32	0.58	2.90
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	87.31	101.87	5.26	4.45	2.02	2.02
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	87.82	110.99	2.85	2.44	2.03	3.25
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	56.74	20.63	1.29	1.29	0.32	0.48
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	53.07	17.44	0.75	1.35	0.30	1.50
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	56.86	19.54	2.63	1.10	0.44	1.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	43.76	19.36	0.50	1.76	0.25	1.51
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	45.21	17.91	1.75	2.18	0.66	0.66
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	50.20	18.56	1.27	1.69	0.42	1.27
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	47.45	18.13	1.07	0.53	0.00	1.07
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	51.15	19.56	1.65	1.81	0.30	0.30
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	53.33	19.91	2.00	1.34	0.53	1.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	55.07	19.51	2.76	1.04	0.52	1.04
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	52.74	21.84	1.94	1.68	0.52	0.90
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	45.86	24.75	0.49	1.70	0.49	0.97
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	56.24	23.99	1.03	0.77	0.77	1.03
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	53.17	23.11	0.95	2.85	2.22	1.58
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	55.50	30.22	0.55	2.75	0.55	1.10
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	65.54	33.01	3.54	2.36	0.00	1.18
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	52.82	19.87	1.45	1.62	0.32	0.65
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	44.16	24.07	1.63	1.63	0.72	1.27
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	46.68	18.21	1.67	1.67	0.42	1.47
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	47.48	17.19	2.15	1.56	0.00	1.37
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	59.30	25.11	2.53	1.06	0.84	1.06
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	58.88	29.36	1.48	2.14	0.66	2.31
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	49.18	22.06	1.87	1.50	0.75	1.12
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	53.46	24.53	0.96	1.34	0.57	0.96
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	44.96	29.02	1.64	1.43	0.61	0.82
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	47.95	22.57	2.22	1.21	0.40	1.41
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	54.56	18.37	1.62	1.89	0.81	1.89
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	49.21	22.33	0.72	1.44	0.72	0.72
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	47.29	27.53	0.94	1.65	0.24	1.88
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	48.02	27.96	1.02	1.17	0.29	1.02
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	51.88	29.31	1.90	0.84	0.00	0.63
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	53.67	26.05	1.57	1.75	0.70	1.22
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	62.64	26.70	2.41	1.20	0.20	0.80
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	52.81	20.24	2.33	1.40	0.93	0.70
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	50.62	26.87	2.40	0.96	0.72	0.72
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	47.69	21.16	1.19	1.49	0.60	0.60
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	48.59	22.50	1.20	2.15	0.72	1.44
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	55.20	23.66	2.63	1.21	1.01	0.40
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	37.71	22.34	0.61	1.84	0.82	1.43
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	35.36	25.35	1.56	2.45	0.89	2.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	111.94	167.91	0.00	13.99	0.00	27.98
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	35.84	16.32	1.77	1.06	0.00	0.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	36.45	16.57	1.66	0.00	0.33	0.66
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	37.75	45.30	6.71	6.71	3.36	1.68
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	33.07	31.23	3.21	1.84	1.84	1.84
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	35.33	21.07	2.59	2.27	0.65	1.62
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	32.76	14.77	1.61	0.64	0.64	0.96
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	28.60	36.46	0.63	3.14	0.00	2.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	35.25	14.81	0.71	1.41	0.71	2.12
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	31.40	14.58	3.36	1.12	1.12	0.56
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	40.60	70.06	0.80	2.39	2.39	3.18
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	25.82	25.82	1.02	1.70	1.36	0.34
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	34.44	20.79	0.65	1.62	0.32	0.65
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	25.91	16.68	1.42	1.77	0.35	1.77
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	0.00	96.98	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	102.67	102.67	0.00	15.79	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	24.86	12.68	0.98	0.49	0.49	0.98
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	20.83	15.87	0.00	1.49	1.49	0.99
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	19.70	14.07	0.47	0.00	0.00	0.94
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	20.20	26.50	0.66	0.66	0.33	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	25.06	11.75	0.62	1.55	0.00	0.93
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	25.99	15.29	2.75	0.31	0.92	1.53
Adipocyte - breast, donor1	11376-118A8	38.65	20.75	0.48	1.27	0.63	0.32
Adipocyte - breast, donor2	11327-117E4	36.26	15.24	1.76	1.93	0.64	3.05
Adipocyte - omental, donor1	11473-119C6	40.20	24.55	1.78	1.15	0.25	0.25
Adipocyte - omental, donor2	11474-119C7	21.68	5.98	1.49	0.75	0.75	0.75
Adipocyte - omental, donor3	11475-119C8	26.46	7.37	2.01	1.67	0.33	0.33
Adipocyte - perirenal, donor1	11476-119C9	23.61	6.38	1.91	0.00	1.28	0.64
Adipocyte - subcutaneous, donor1	11259-116F8	16.49	15.39	1.10	2.20	0.00	1.10
Adipocyte - subcutaneous, donor2	11336-117F4	30.71	9.94	0.90	0.90	0.00	1.35
Adipocyte - subcutaneous, donor3	11408-118E4	54.91	22.76	1.04	2.61	0.17	0.35
Adipocyte differentiation, day04, donor1	13019-139D4	86.05	32.07	2.35	2.74	0.78	0.00
Adipocyte differentiation, day04, donor2	13022-139D7	45.04	37.58	1.80	2.83	1.03	0.26
Adipocyte differentiation, day04, donor3	13025-139E1	41.82	28.99	2.51	3.35	0.28	0.00
Adipocyte differentiation, day04, donor4	13028-139E4	68.77	45.26	2.35	2.94	1.76	0.00
Adipocyte differentiation, day08, donor1	13020-139D5	75.37	26.22	4.67	2.09	1.05	0.32
Adipocyte differentiation, day08, donor2	13023-139D8	56.48	27.43	1.94	2.26	0.65	0.32
Adipocyte differentiation, day08, donor3	13026-139E2	46.92	26.66	3.20	2.67	2.13	0.00
Adipocyte differentiation, day08, donor4	13029-139E5	46.74	25.04	2.78	5.01	0.00	0.56
Adipocyte differentiation, day12, donor1	13021-139D6	40.34	16.22	4.16	0.83	0.42	0.42
Adipocyte differentiation, day12, donor2	13024-139D9	36.92	21.85	2.51	1.51	1.26	0.75
Adipocyte differentiation, day12, donor3	13027-139E3	36.00	19.63	1.96	0.65	1.64	0.00
Adipocyte differentiation, day12, donor4	13030-139E6	39.28	18.88	3.65	2.13	0.61	0.30
Alveolar Epithelial Cells, donor1	11510-119G7	87.52	41.33	4.64	1.99	0.88	1.33
Alveolar Epithelial Cells, donor2	11590-120G6	80.32	27.25	7.53	2.51	1.43	1.79
Alveolar Epithelial Cells, donor3	11671-122G6	56.31	27.55	0.00	1.20	1.20	2.40
Amniotic Epithelial Cells, donor1	11533-120A3	57.93	41.38	1.98	4.32	0.72	0.36
Amniotic Epithelial Cells, donor2	11613-122A2	60.25	30.12	0.00	11.71	0.00	0.00
Amniotic Epithelial Cells, donor3	11694-123A2	51.57	40.68	2.05	5.55	0.00	0.82
Anulus Pulposus Cell, donor1	11248-116E6	34.67	9.15	1.60	1.37	0.11	0.11
Anulus Pulposus Cell, donor2	11463-119B5	28.41	3.18	1.47	1.22	0.24	0.24
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	21.57	8.54	1.35	1.35	0.90	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	17.37	8.25	1.30	2.60	1.30	0.43
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	19.26	12.84	0.00	2.14	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	16.44	13.15	2.39	0.00	0.60	0.30
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	17.71	6.32	0.00	3.79	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	22.44	12.54	0.66	0.66	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	18.84	9.42	0.97	2.27	0.32	0.65
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	14.56	10.68	0.49	0.49	0.49	1.94
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	16.63	8.91	1.78	2.38	0.59	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	18.46	12.43	0.75	0.00	0.38	0.38
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	11.61	7.98	2.18	1.45	0.73	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	17.55	12.54	0.00	2.51	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	22.73	9.72	1.32	0.66	0.82	0.33
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	13.65	8.19	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	17.04	6.03	0.75	0.75	0.45	0.15
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	23.04	8.04	0.00	1.61	0.00	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	20.22	9.26	1.89	1.32	0.57	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	19.51	11.23	0.27	2.41	0.53	0.27
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	17.56	12.68	2.93	0.98	0.00	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	19.24	7.13	1.33	0.66	0.50	0.17
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	16.81	1.20	0.00	0.00	0.00	3.60
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	24.78	10.62	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	18.70	8.40	0.51	2.06	0.69	0.69
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	8.39	8.39	0.00	4.19	4.19	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	14.56	8.74	2.43	1.46	0.00	0.49
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	16.32	8.73	1.52	0.76	0.76	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	12.11	8.48	2.42	2.42	0.00	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	10.26	6.27	0.00	1.71	0.00	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	19.67	9.41	1.92	0.64	0.43	0.64
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	24.26	6.45	1.03	1.29	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	17.36	7.98	1.41	0.94	0.94	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	15.76	8.04	0.32	1.29	0.32	0.32
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	17.84	10.70	2.14	0.71	0.71	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	13.45	9.36	2.34	0.58	1.75	0.58
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	23.48	9.63	1.51	1.51	0.30	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	24.95	8.32	0.00	1.19	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	15.26	8.65	2.54	0.51	0.51	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	16.55	10.44	1.27	0.51	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	19.70	6.99	0.64	0.64	0.64	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	12.95	11.22	1.73	1.29	0.00	0.43
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	23.07	9.31	2.54	0.85	0.85	0.64
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	16.53	6.38	2.32	1.45	0.87	0.87
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	15.12	9.45	0.94	0.00	0.94	0.94
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	18.31	7.46	0.68	0.68	0.17	0.68
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	11.58	9.27	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	29.58	10.56	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	16.08	9.65	1.07	1.29	0.21	0.21
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	21.66	11.43	0.00	2.41	0.00	1.20
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	14.58	4.37	2.19	1.46	0.00	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	18.16	7.59	1.38	0.69	0.00	0.92
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	30.60	10.20	0.00	2.55	0.00	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	17.80	4.83	0.25	0.51	0.76	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	25.80	11.15	1.03	1.45	0.41	1.03
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	20.81	8.87	0.31	0.92	0.61	0.92
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	13.38	6.69	2.87	0.96	0.00	0.96
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	21.51	8.20	1.33	1.11	0.44	0.44
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	7.63	10.68	1.53	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	16.06	6.09	0.55	0.55	0.55	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	19.33	14.03	1.85	1.85	0.26	0.26
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	21.08	8.72	0.00	0.36	1.09	0.73
Astrocyte - cerebellum, donor1	11500-119F6	88.67	40.41	4.42	3.56	1.35	0.98
Astrocyte - cerebellum, donor2	11580-120F5	105.95	26.02	6.85	2.57	1.37	0.86
Astrocyte - cerebellum, donor3	11661-122F5	75.72	44.68	2.31	2.73	0.00	1.26
Astrocyte - cerebral cortex, donor1	11235-116D2	82.61	25.80	5.23	1.39	0.00	0.70
Astrocyte - cerebral cortex, donor2	11316-117D2	82.18	34.30	5.82	1.62	0.81	0.97
Astrocyte - cerebral cortex, donor3	11392-118C6	105.16	33.11	3.58	1.64	1.34	1.19
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	190.49	44.61	7.00	3.33	4.82	4.24
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	199.70	52.12	9.02	4.13	5.26	3.38
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	186.97	48.14	7.28	4.55	4.32	3.87
Basophils, donor1	12241-129G9	161.63	159.53	6.54	10.98	3.14	0.26
Basophils, donor2	12242-129H1	201.68	110.76	9.02	7.22	7.94	0.00
Basophils, donor3	12243-129H2	161.84	51.60	6.61	5.14	4.85	0.29
Bronchial Epithelial Cell, donor1	11511-119G8	42.47	27.60	2.16	2.59	0.43	0.22
Bronchial Epithelial Cell, donor2	11591-120G7	63.09	31.09	3.66	5.03	0.91	1.37
Bronchial Epithelial Cell, donor3	11672-122G7	28.69	35.87	7.17	14.35	0.00	0.00
Bronchial Epithelial Cell, donor4	11453-119A4	67.16	19.46	6.90	1.88	0.63	0.00
Bronchial Epithelial Cell, donor5	11457-119A8	99.82	31.61	7.07	2.08	1.25	1.25
Bronchial Epithelial Cell, donor6	11461-119B3	58.26	34.08	3.22	1.15	0.46	0.92
Bronchial Epithelial Cell, donor7	11769-123I5	21.95	30.59	0.54	3.42	0.36	0.18
Burkitt's lymphoma cell line:DAUDI	10422-106C8	174.99	53.79	8.76	2.78	2.89	1.34
Burkitt's lymphoma cell line:RAJI	10476-106I8	144.40	33.54	5.59	2.33	1.63	1.63
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	155.09	64.59	3.52	2.56	0.96	0.32
CD133+ stem cells - cord blood derived, pool1	12223-129E9	268.89	82.74	10.34	0.00	0.00	0.00
CD14+ Monocytes, donor1	11224-116B9	218.10	52.97	5.64	2.82	2.82	0.00
CD14+ Monocytes, donor2	11305-117B9	199.89	81.85	4.64	3.53	5.20	4.08
CD14+ Monocytes, donor3	11381-118B4	200.88	67.84	9.44	3.07	3.51	1.76
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	52.36	43.87	2.26	5.09	0.00	0.00
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	65.58	55.72	3.79	3.03	1.90	0.00
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	63.45	60.49	2.63	5.92	1.64	0.33
CD14+ monocytes - mock treated, donor1	11863-125A9	90.78	77.77	5.64	6.65	1.73	1.59
CD14+ monocytes - mock treated, donor2	11873-125C1	87.51	75.44	6.03	4.22	1.21	3.02
CD14+ monocytes - mock treated, donor3	11883-125D2	112.05	79.12	4.03	7.58	2.13	0.95
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	66.29	76.84	3.01	4.69	1.17	2.01
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	86.39	70.93	1.66	3.04	0.83	2.21
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	90.00	70.41	3.22	6.20	1.24	0.99
CD14+ monocytes - treated with BCG, donor1	11860-125A6	56.59	61.29	2.74	5.48	0.98	0.98
CD14+ monocytes - treated with BCG, donor2	11870-125B7	76.56	54.84	6.05	3.03	1.07	1.07
CD14+ monocytes - treated with BCG, donor3	11880-125C8	68.12	56.37	1.52	1.74	1.74	0.87
CD14+ monocytes - treated with Candida, donor1	11868-125B5	88.73	80.54	2.34	7.73	0.70	0.94
CD14+ monocytes - treated with Candida, donor2	11878-125C6	137.29	98.21	4.75	3.70	2.11	1.58
CD14+ monocytes - treated with Candida, donor3	11888-125D7	118.70	107.61	0.00	0.00	2.22	2.22
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	72.74	70.51	3.27	5.06	1.49	2.23
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	71.24	63.86	3.99	4.79	1.40	1.20
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	59.96	56.01	2.08	2.91	0.83	0.62
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	65.43	72.98	2.75	6.86	2.29	1.60
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	82.11	94.10	1.13	4.52	1.81	0.90
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	72.02	75.94	4.36	6.11	3.06	0.87
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	68.59	66.44	5.92	5.11	1.88	2.15
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	88.45	64.03	5.23	4.01	1.05	2.27
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	93.84	74.06	2.95	7.15	1.26	1.26
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	46.11	54.38	3.12	4.78	0.92	0.37
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	61.65	70.45	1.76	2.47	0.35	1.06
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	61.42	71.07	1.75	4.83	0.44	0.44
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	66.09	57.72	2.79	5.41	0.52	2.44
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	79.17	72.48	5.58	5.58	2.97	0.37
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	89.24	66.39	2.37	2.80	3.02	0.65
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	67.57	55.28	3.28	4.50	0.41	1.23
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	56.79	68.38	3.01	4.64	0.70	0.70
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	58.69	49.88	0.93	2.09	0.70	0.23
CD14+CD16+ Monocytes, donor1	11789-124B7	57.76	43.16	3.71	3.49	1.53	0.22
CD14+CD16+ Monocytes, donor2	11801-124D1	60.52	54.75	2.31	2.31	1.15	0.69
CD14+CD16+ Monocytes, donor3	11912-125G4	54.59	37.47	2.17	1.30	1.30	0.22
CD14+CD16- Monocytes, donor1	11788-124B6	118.19	92.50	5.45	6.38	2.96	0.93
CD14+CD16- Monocytes, donor2	11799-124C8	79.46	75.97	2.79	5.76	1.75	0.17
CD14+CD16- Monocytes, donor3	11910-125G2	149.17	124.64	4.46	5.35	2.90	0.45
CD14-CD16+ Monocytes, donor1	11790-124B8	60.22	64.30	4.34	1.79	1.28	0.00
CD14-CD16+ Monocytes, donor2	11800-124C9	50.94	62.14	2.85	4.39	1.10	0.22
CD14-CD16+ Monocytes, donor3	11911-125G3	56.22	57.48	4.21	1.89	1.68	0.42
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	189.00	58.94	8.13	0.00	2.03	0.00
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	168.14	61.70	13.56	2.03	2.71	0.68
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	160.52	56.96	8.28	3.11	2.07	1.04
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	141.79	79.96	9.06	2.13	5.33	0.00
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	179.05	84.70	8.04	3.75	5.36	0.00
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	160.74	74.41	9.13	2.11	2.11	0.70
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	147.46	65.10	9.41	0.78	4.71	0.78
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	143.69	109.42	9.23	1.32	5.27	0.00
CD19+ B Cells, donor1	11544-120B5	373.96	123.29	21.37	4.93	8.22	3.29
CD19+ B Cells, donor2	11624-122B4	335.15	103.01	11.61	5.08	9.43	2.18
CD19+ B Cells, donor3	11705-123B4	326.12	124.69	30.29	4.54	10.10	2.52
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	90.51	67.48	2.02	2.02	0.81	0.81
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	65.52	37.55	0.00	0.00	2.00	0.40
CD34+ Progenitors, donor1	11545-120B6	187.76	57.23	7.03	6.02	1.00	0.00
CD34+ Progenitors, donor2	11625-122B5	179.78	51.12	6.18	6.18	1.69	0.56
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	131.89	45.47	6.01	1.88	3.38	1.50
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	139.12	56.60	3.83	3.83	3.61	0.45
CD4+ T Cells, donor1	11225-116C1	597.00	298.50	29.28	11.43	14.64	3.21
CD4+ T Cells, donor2	11306-117C1	470.29	233.31	24.49	7.96	11.63	9.80
CD4+ T Cells, donor3	11382-118B5	387.34	158.60	20.74	8.23	10.06	3.05
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	105.16	55.64	9.19	3.06	3.06	0.51
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	121.28	65.81	6.29	2.02	4.04	0.45
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	144.59	61.23	7.47	1.72	2.59	0.29
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	309.58	209.07	19.91	5.69	5.22	1.90
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	285.14	219.12	18.96	5.62	4.92	2.81
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	253.81	184.59	6.59	3.30	9.89	3.30
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	89.74	32.95	7.23	1.88	3.61	1.45
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	104.22	33.21	11.02	1.86	3.05	1.36
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	100.11	28.21	9.83	1.61	3.55	1.13
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	156.46	119.25	13.90	5.38	6.28	1.34
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	154.43	94.68	10.48	4.19	5.59	1.75
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	180.83	130.67	7.92	4.40	3.96	0.44
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	125.23	57.34	7.17	2.11	4.22	2.11
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	106.38	39.27	6.65	1.87	2.29	1.25
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	98.57	32.08	7.02	2.34	3.01	0.33
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	279.00	215.92	13.05	8.43	6.80	3.26
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	340.86	254.58	20.37	9.11	7.50	2.14
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	294.09	186.50	21.52	10.76	5.38	3.59
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	135.18	48.03	11.87	1.85	4.64	1.11
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	107.44	33.79	9.53	1.52	5.42	1.08
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	106.97	31.31	8.62	0.84	5.04	0.42
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	218.93	122.36	15.67	4.55	6.07	1.01
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	195.83	120.44	14.30	3.47	4.77	1.73
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	243.18	147.74	10.02	4.36	10.02	2.18
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	206.36	111.84	6.43	3.46	6.43	0.49
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	172.64	76.62	8.31	0.92	2.77	0.00
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	145.17	72.58	9.77	1.40	6.98	0.00
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	176.13	83.91	14.12	3.88	3.88	0.55
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	177.66	82.94	18.65	4.66	5.64	0.74
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	241.78	133.98	9.24	1.54	4.62	0.00
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	174.40	101.35	8.24	2.15	2.86	0.72
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	188.36	85.87	11.08	1.38	5.54	0.00
CD8+ T Cells, donor1	11226-116C2	429.22	123.10	27.50	3.93	13.75	1.64
CD8+ T Cells, donor2	11307-117C2	364.17	111.88	23.65	3.00	11.26	4.88
CD8+ T Cells, donor3	11383-118B6	489.58	182.04	28.03	5.05	16.16	2.02
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	98.64	23.40	4.13	0.92	3.44	0.92
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	102.33	24.44	3.59	1.44	2.16	0.48
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	109.98	26.54	4.65	2.19	2.19	2.74
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	85.86	28.52	6.90	0.60	3.00	2.10
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	105.35	21.12	5.04	0.72	1.68	3.60
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	108.92	25.01	5.68	0.68	3.18	0.91
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	85.83	15.64	6.95	0.00	3.04	1.30
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	84.23	18.42	7.11	0.26	2.11	1.32
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	87.47	19.00	5.16	0.23	2.11	1.41
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	69.43	15.09	7.85	0.30	4.53	0.60
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	79.02	19.75	4.07	1.16	3.20	0.87
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	80.20	15.19	5.60	0.00	2.93	0.53
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	77.48	11.38	4.38	0.00	3.06	0.44
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	85.62	17.31	7.29	0.91	0.91	1.82
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	97.71	17.90	5.22	1.49	1.49	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	109.49	18.73	4.32	1.08	1.80	1.08
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	95.52	24.17	6.33	0.00	3.45	3.16
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	115.26	22.86	7.07	0.94	2.36	1.41
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	108.70	25.67	7.92	0.63	3.80	4.12
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	100.27	19.68	5.23	0.31	3.08	0.62
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	88.48	13.79	3.85	0.32	3.53	1.28
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	79.55	10.33	4.97	0.38	4.21	1.15
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	79.61	15.37	3.15	0.00	3.55	1.18
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	68.83	17.40	0.76	0.76	3.03	0.76
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	100.37	28.10	7.23	1.61	0.80	1.61
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	109.81	33.57	2.80	0.70	0.70	2.10
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	127.22	27.05	5.01	1.00	1.00	0.00
Cardiac Myocyte, donor1	11525-119I4	93.21	21.93	1.83	0.00	1.83	0.00
Cardiac Myocyte, donor2	11605-120I3	25.69	13.83	0.99	0.49	0.49	0.00
Cardiac Myocyte, donor3	11686-122I3	32.20	17.15	1.16	0.53	0.53	0.21
Chondrocyte - de diff, donor1	11261-116G1	38.83	12.13	4.16	1.04	1.73	0.35
Chondrocyte - de diff, donor2	11338-117F6	44.42	14.93	0.71	2.84	1.07	1.07
Chondrocyte - de diff, donor3	11410-118E6	40.96	22.64	1.37	1.37	0.34	1.48
Chondrocyte - re diff, donor2	11339-117F7	75.20	62.67	5.37	3.58	0.90	0.00
Chondrocyte - re diff, donor3	11411-118E7	48.53	42.87	1.62	2.43	0.40	0.00
Ciliary Epithelial Cells, donor1	11242-116D9	70.69	37.87	2.87	2.07	0.92	0.34
Ciliary Epithelial Cells, donor2	11323-117D9	58.79	31.85	3.63	1.71	0.86	0.43
Ciliary Epithelial Cells, donor3	11399-118D4	70.53	28.94	3.36	2.30	1.33	0.35
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	111.32	105.18	10.00	8.99	7.34	1.65
Corneal Epithelial Cells, donor1	11526-119I5	65.43	41.94	2.63	3.95	0.88	1.10
Corneal Epithelial Cells, donor2	11606-120I4	56.88	30.72	6.83	2.28	1.14	3.41
Corneal Epithelial Cells, donor3	11687-122I4	59.05	27.35	4.35	1.02	1.53	0.77
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	62.41	21.96	4.95	1.32	1.98	0.50
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	61.19	24.29	2.84	1.89	1.58	0.00
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	72.46	31.06	6.90	3.45	6.90	0.00
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	52.91	17.39	4.86	1.40	1.19	0.32
Dendritic Cells - plasmacytoid, donor1	11228-116C4	239.83	84.39	12.98	5.81	4.78	1.02
Dendritic Cells - plasmacytoid, donor2	11309-117C4	255.27	70.51	6.53	5.88	8.49	0.00
Dendritic Cells - plasmacytoid, donor3	11385-118B8	213.90	68.24	16.94	3.87	6.78	0.00
Endothelial Cells - Aortic, donor0	11207-116A1	112.07	33.02	6.00	1.50	2.00	0.67
Endothelial Cells - Aortic, donor1	11263-116G3	56.92	18.78	2.93	0.59	1.17	0.00
Endothelial Cells - Aortic, donor2	11340-117F8	83.99	35.35	1.41	2.83	0.85	0.57
Endothelial Cells - Aortic, donor3	11412-118E8	112.45	32.63	4.33	1.18	1.57	0.39
Endothelial Cells - Artery, donor1	11264-116G4	44.21	26.18	2.04	0.58	1.16	0.29
Endothelial Cells - Artery, donor2	11341-117F9	74.35	40.23	4.71	0.94	1.18	2.82
Endothelial Cells - Artery, donor3	11413-118E9	102.91	30.68	6.31	2.80	1.40	1.05
Endothelial Cells - Lymphatic, donor1	11236-116D3	57.41	21.06	1.77	0.89	0.22	0.66
Endothelial Cells - Lymphatic, donor2	11317-117D3	55.07	23.43	2.43	0.61	1.22	0.30
Endothelial Cells - Lymphatic, donor3	11393-118C7	51.87	21.99	1.13	0.85	0.28	0.28
Endothelial Cells - Microvascular, donor1	11265-116G5	32.09	14.26	0.89	2.67	0.59	0.30
Endothelial Cells - Microvascular, donor2	11342-117G1	48.42	26.03	2.60	1.04	1.04	0.52
Endothelial Cells - Microvascular, donor3	11414-118F1	45.51	19.57	0.99	1.84	0.99	0.57
Endothelial Cells - Thoracic, donor1	11266-116G6	59.22	20.01	6.40	2.00	0.80	0.80
Endothelial Cells - Thoracic, donor2	11343-117G2	43.50	20.44	0.52	0.52	0.52	1.57
Endothelial Cells - Umbilical vein, donor1	11243-116E1	117.04	33.42	4.72	3.23	1.74	0.25
Endothelial Cells - Umbilical vein, donor2	11324-117E1	104.50	26.29	5.00	2.39	0.87	0.00
Endothelial Cells - Umbilical vein, donor3	11400-118D5	122.37	30.65	5.50	1.95	0.98	0.37
Endothelial Cells - Vein, donor1	11267-116G7	84.18	37.54	3.41	2.28	3.41	0.00
Endothelial Cells - Vein, donor2	11344-117G3	99.89	50.29	4.19	3.49	0.70	0.70
Endothelial Cells - Vein, donor3	11416-118F3	89.49	29.36	2.51	0.94	0.63	1.10
Eosinophils, donor1	12244-129H3	137.22	45.74	15.25	0.00	0.00	0.00
Eosinophils, donor2	12245-129H4	377.91	539.64	41.26	31.35	41.26	0.00
Eosinophils, donor3	12246-129H5	274.65	477.95	10.70	14.27	28.53	3.57
Esophageal Epithelial Cells, donor1	11507-119G4	49.11	26.39	0.24	3.42	0.49	0.49
Esophageal Epithelial Cells, donor2	11587-120G3	52.00	10.40	2.08	0.00	0.00	0.00
Esophageal Epithelial Cells, donor3	11668-122G3	16.27	0.00	0.00	0.00	0.00	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	36.95	14.37	2.46	0.41	0.41	0.41
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	12.48	7.12	1.20	0.66	0.33	0.77
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	29.25	10.08	1.84	1.19	0.43	1.19
Fibroblast - Aortic Adventitial, donor1	11245-116E3	43.05	22.68	1.58	1.70	0.36	0.24
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	57.18	32.07	3.41	1.64	1.77	0.41
Fibroblast - Aortic Adventitial, donor2	11326-117E3	40.08	17.40	2.53	0.95	0.42	1.48
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	32.15	36.89	4.74	1.58	0.79	0.26
Fibroblast - Aortic Adventitial, donor3	11401-118D6	62.12	30.89	3.99	1.66	1.00	1.66
Fibroblast - Cardiac, donor1	11268-116G8	36.29	19.96	2.27	2.72	1.81	1.36
Fibroblast - Cardiac, donor2	11345-117G4	68.97	36.38	4.55	0.76	2.27	0.00
Fibroblast - Cardiac, donor3	11417-118F4	33.28	22.40	1.58	1.10	0.63	0.63
Fibroblast - Cardiac, donor4	11452-119A3	74.87	24.85	1.82	0.91	0.91	0.91
Fibroblast - Cardiac, donor5	11456-119A7	46.32	14.72	3.43	1.27	0.51	0.51
Fibroblast - Cardiac, donor6	11460-119B2	60.64	11.82	3.79	1.06	0.76	0.30
Fibroblast - Choroid Plexus, donor1	11492-119E7	61.77	29.08	3.08	3.35	0.80	1.07
Fibroblast - Choroid Plexus, donor2	11572-120E6	34.51	25.89	0.00	2.16	0.00	0.43
Fibroblast - Choroid Plexus, donor3	11653-122E6	36.62	35.16	0.00	0.00	0.00	0.00
Fibroblast - Conjunctival, donor1	11531-120A1	187.74	48.66	4.84	1.15	2.31	1.15
Fibroblast - Conjunctival, donor3	11692-122I9	63.09	16.62	0.68	3.22	0.85	0.00
Fibroblast - Dermal, donor1	11269-116G9	32.40	10.80	1.17	0.23	2.11	0.23
Fibroblast - Dermal, donor2	11346-117G5	85.85	35.38	3.30	1.89	1.42	0.47
Fibroblast - Dermal, donor3	11418-118F5	51.01	9.55	2.18	1.21	1.09	0.48
Fibroblast - Dermal, donor4	11450-119A1	73.59	18.43	3.73	1.92	0.90	0.34
Fibroblast - Dermal, donor5	11454-119A5	92.81	16.22	5.76	1.57	1.40	1.22
Fibroblast - Dermal, donor6	11458-119A9	98.92	17.22	5.20	1.79	0.81	1.46
Fibroblast - Gingival, donor1	11237-116D4	58.51	18.74	1.67	1.67	0.21	0.62
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	73.88	34.06	3.67	2.36	1.05	0.79
Fibroblast - Gingival, donor2	11318-117D4	67.08	22.27	2.24	1.71	0.66	0.53
Fibroblast - Gingival, donor3	11394-118C8	76.77	17.21	3.09	1.93	0.68	0.87
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	63.37	19.74	1.04	3.12	0.00	0.00
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	47.93	27.49	1.94	1.06	0.70	1.41
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	95.41	27.59	6.55	2.96	2.03	0.78
Fibroblast - Gingival, donor6 (control)	11922-125H5	62.88	24.07	4.19	1.89	1.35	0.41
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	102.69	88.22	6.70	7.76	3.88	0.71
Fibroblast - Gingival, donor7 (control)	11924-125H7	80.14	25.59	3.80	1.75	0.73	0.44
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	64.77	26.59	3.68	2.45	0.95	0.82
Fibroblast - Gingival, donor8 (control)	11926-125H9	99.38	26.44	4.83	2.74	1.86	0.88
Fibroblast - Gingival, donor9 (control)	11927-125I1	58.40	61.48	2.35	4.55	1.03	0.73
Fibroblast - Lung, donor1	11270-116H1	70.69	12.23	2.72	1.36	5.44	0.00
Fibroblast - Lung, donor2	11347-117G6	50.73	20.89	1.49	1.49	1.49	0.00
Fibroblast - Lung, donor3	11419-118F6	73.65	15.19	2.32	1.06	1.06	1.06
Fibroblast - Lymphatic, donor1	11506-119G3	160.77	35.82	6.66	10.00	0.00	0.83
Fibroblast - Lymphatic, donor2	11586-120G2	69.93	5.59	4.20	0.00	0.00	0.00
Fibroblast - Lymphatic, donor3	11667-122G2	59.05	19.59	1.12	1.40	0.00	1.12
Fibroblast - Mammary, donor1	11540-120B1	156.70	58.46	6.90	5.28	3.65	0.81
Fibroblast - Mammary, donor2	11620-122A9	111.84	31.95	0.00	7.99	0.00	3.99
Fibroblast - Mammary, donor3	11701-123A9	131.04	23.83	17.87	0.00	0.00	0.00
Fibroblast - Periodontal Ligament, donor1	11238-116D5	61.10	21.92	1.16	1.94	0.19	1.16
Fibroblast - Periodontal Ligament, donor2	11319-117D5	107.54	37.16	3.94	3.19	0.46	2.73
Fibroblast - Periodontal Ligament, donor3	11395-118C9	82.31	25.70	3.06	1.84	1.22	0.31
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	41.22	26.33	3.05	0.38	1.53	0.38
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	43.47	21.06	2.43	2.97	0.27	0.81
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	56.60	27.72	2.44	1.86	0.81	0.23
Fibroblast - Pulmonary Artery, donor1	11250-116E8	33.05	13.48	1.11	0.44	0.88	0.66
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	122.93	51.61	6.10	4.06	2.44	0.61
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	101.57	36.75	3.34	1.34	0.67	0.00
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	35.19	13.44	0.79	2.37	0.00	0.40
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	48.62	46.04	4.56	5.56	0.40	1.79
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	37.30	21.85	1.78	3.37	0.00	0.36
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	54.00	24.44	1.97	0.39	0.20	1.77
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	46.63	29.78	3.01	1.81	0.90	0.60
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	60.24	18.24	3.78	2.48	0.32	0.65
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	48.08	33.41	3.29	1.77	0.76	0.51
Fibroblast - skin normal, donor1	11553-120C5	42.00	14.60	1.48	1.31	0.33	1.15
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	74.39	41.71	3.81	3.61	1.80	0.40
Fibroblast - skin normal, donor2	11561-120D4	46.51	17.08	2.11	1.91	1.21	0.70
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	50.78	41.41	3.63	4.84	0.30	0.30
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	61.14	26.01	1.66	2.32	0.75	0.58
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	57.95	17.78	2.22	1.71	1.20	0.68
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	32.51	32.84	1.31	3.94	1.31	0.99
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	42.50	15.13	3.62	1.60	0.85	0.21
Fibroblast - skin walker warburg, donor1	11554-120C6	55.16	17.37	1.69	0.17	0.67	1.35
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	24.46	15.05	1.41	1.25	0.16	1.10
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	110.80	44.32	0.00	0.00	22.16	0.00
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	67.11	31.38	6.10	2.61	0.87	0.87
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	39.01	23.58	0.52	1.39	1.04	0.00
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	49.97	34.87	2.60	2.60	0.78	0.26
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	58.77	38.07	2.81	3.32	1.28	0.26
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	107.94	114.07	5.36	8.42	2.30	0.77
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	119.32	96.99	4.47	5.74	3.19	3.19
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	91.85	89.86	3.14	6.85	0.86	1.43
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	145.88	147.25	1.93	12.68	0.55	1.10
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	172.84	100.46	3.42	7.53	1.37	0.91
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	117.09	91.73	4.16	6.34	0.40	0.40
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	136.93	135.08	4.23	9.52	0.79	1.06
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	219.50	81.86	10.44	6.52	2.94	0.65
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	93.31	63.68	1.33	5.75	0.88	0.88
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	70.80	59.92	1.84	4.38	0.71	0.99
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	65.76	48.52	2.34	4.19	0.25	1.48
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	68.50	47.55	2.69	3.22	0.00	1.61
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	65.66	56.74	2.35	3.22	0.50	1.36
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	83.47	45.68	2.21	3.88	0.69	2.08
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	61.60	41.68	1.83	3.66	0.61	2.24
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	51.80	42.67	2.05	3.42	0.46	0.91
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	60.29	43.85	2.12	3.49	0.25	1.00
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	69.29	46.78	1.75	4.59	1.09	1.09
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	59.39	52.30	2.66	6.21	0.30	2.36
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	75.82	44.67	1.75	2.70	0.48	1.43
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	68.14	46.02	2.23	3.35	0.22	0.45
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	74.40	55.05	1.21	4.23	0.20	1.21
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	77.53	44.79	4.58	2.88	0.85	1.02
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	103.57	60.83	1.86	3.81	0.80	2.31
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	115.92	93.55	2.71	8.01	0.83	2.81
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	98.54	89.66	1.20	6.49	0.68	2.90
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	81.66	54.99	2.77	4.43	0.77	1.00
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	85.78	53.91	2.25	3.49	0.75	0.67
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	75.96	49.62	1.02	5.72	0.20	0.61
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	55.29	56.12	1.65	2.48	0.21	1.03
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	76.44	57.30	1.38	5.19	0.58	0.92
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	67.04	41.52	2.33	3.50	1.33	0.67
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	48.49	45.63	1.10	3.97	0.22	1.54
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	70.23	65.43	1.60	3.57	1.23	1.23
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	67.75	52.19	3.73	2.43	0.49	1.30
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	60.29	69.27	1.28	6.41	0.64	1.60
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	58.46	37.52	2.18	3.79	0.66	0.66
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	54.25	31.95	1.90	3.01	0.16	0.16
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	48.35	51.09	2.13	3.95	0.00	1.52
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	53.63	31.15	1.46	2.40	0.52	0.52
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	43.47	30.74	1.32	2.63	0.88	0.22
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	40.96	40.96	1.40	3.65	0.56	1.40
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	66.85	27.22	3.89	2.41	0.74	1.11
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	45.73	19.52	2.41	1.60	1.07	0.53
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	53.25	27.69	2.30	1.99	0.92	1.07
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	48.96	23.83	2.72	1.04	0.78	1.42
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	47.17	17.08	1.63	1.08	0.81	1.08
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	52.17	33.92	1.29	3.13	0.18	1.84
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	47.15	42.33	1.32	2.41	0.44	0.44
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	74.38	50.58	0.99	5.95	1.98	0.00
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	53.69	32.19	2.11	1.71	1.19	1.06
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	46.81	22.80	1.61	1.61	0.20	1.41
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	162.66	73.71	4.57	7.12	1.02	1.27
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	91.17	62.11	3.58	6.57	0.00	1.39
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	89.21	64.71	2.93	4.47	0.62	0.46
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	141.98	105.16	5.11	7.77	2.25	1.23
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	76.04	50.69	2.19	3.13	0.63	0.31
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	74.31	39.84	1.70	2.83	0.85	1.13
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	96.39	70.56	4.61	5.53	2.31	2.77
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	69.29	49.50	2.47	4.95	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	93.61	63.44	6.19	3.48	2.71	0.39
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	89.85	40.11	3.21	4.81	1.60	3.21
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	76.51	66.08	3.48	0.00	1.74	3.48
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	70.95	51.43	3.25	3.25	0.65	1.30
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	86.48	52.71	4.12	4.53	0.41	2.47
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	89.97	86.64	0.00	3.33	0.00	10.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	71.87	54.53	2.80	2.80	0.56	0.84
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	64.72	51.64	2.61	5.56	0.98	1.63
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	73.82	59.56	1.68	4.19	0.00	0.84
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	72.20	73.16	2.54	4.13	0.64	0.32
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	66.23	49.59	1.70	4.42	0.34	2.38
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	60.56	43.85	0.00	0.00	4.18	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	85.90	87.05	2.29	9.74	1.15	1.72
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	57.12	56.24	1.18	4.44	0.30	0.30
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	67.77	30.49	1.69	1.69	1.69	3.39
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	80.36	65.86	2.90	2.90	0.00	1.24
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	88.60	59.14	3.45	3.22	0.23	1.38
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	79.03	42.15	5.27	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	62.66	47.28	0.77	4.61	0.77	1.15
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	53.46	34.55	0.65	3.26	0.65	0.98
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	52.84	25.42	0.00	3.34	0.00	1.34
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	69.73	68.58	0.77	3.85	1.16	1.16
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	114.34	124.27	4.79	5.14	1.03	2.05
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	69.57	89.45	0.00	14.91	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	57.57	75.97	0.47	5.19	0.00	0.94
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	63.37	60.35	0.60	3.02	0.60	0.60
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	63.58	57.99	0.00	7.12	1.53	1.02
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	84.55	66.21	2.39	6.78	0.00	2.79
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	68.08	52.30	0.49	7.40	0.00	2.47
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	61.38	74.37	2.36	4.72	1.18	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	60.09	57.18	0.58	1.75	0.00	0.58
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	60.57	76.37	0.44	8.34	0.88	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	67.82	66.12	4.24	1.70	2.54	0.85
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	62.68	45.96	0.00	0.00	0.60	2.98
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	52.89	39.79	0.49	0.97	0.49	0.97
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	42.23	20.54	0.00	4.57	2.28	1.14
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	47.82	24.12	2.08	0.83	2.08	0.42
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	70.84	30.36	3.37	4.50	2.25	0.00
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	26.64	16.18	0.63	2.22	0.00	0.63
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	10.44	8.77	0.42	0.42	0.42	0.84
Hep-2 cells mock treated, biol_rep1	11898-125E8	62.31	11.60	5.57	0.23	1.74	0.58
Hep-2 cells mock treated, biol_rep2	11899-125E9	67.86	16.04	3.71	0.51	1.86	0.68
Hep-2 cells mock treated, biol_rep3	11900-125F1	57.10	15.02	4.78	0.46	2.28	0.46
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	60.78	12.35	5.14	1.42	1.86	0.87
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	59.10	13.11	5.59	0.43	2.58	0.64
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	60.92	13.35	2.80	0.22	1.72	1.08
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	55.29	12.45	3.99	0.25	1.25	0.75
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	53.70	10.12	2.74	0.69	1.54	0.86
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	46.45	14.74	3.52	0.00	1.28	0.32
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	77.23	17.35	2.24	0.00	0.56	0.00
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	90.45	52.37	5.63	3.90	0.00	0.43
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	37.01	26.44	0.00	0.00	2.64	0.00
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	86.77	29.28	1.76	2.12	0.35	0.35
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	90.81	22.52	2.18	0.73	0.73	0.73
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	29.72	10.49	2.10	0.87	0.52	1.05
Hepatocyte, donor1	11523-119I2	65.37	54.48	6.05	7.26	1.21	1.21
Hepatocyte, donor2	11603-120I1	50.63	40.94	3.23	1.08	1.08	0.00
Hepatocyte, donor3	11684-122I1	55.83	39.27	2.45	0.61	1.84	0.61
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	210.17	58.74	7.83	3.92	3.92	0.65
Intestinal epithelial cells (polarized), donor1	11246-116E4	69.39	66.07	2.45	2.80	0.87	0.52
Iris Pigment Epithelial Cells, donor1	11530-119I9	34.30	16.88	1.23	1.65	0.00	0.14
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	120.99	54.13	0.00	3.18	3.18	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	40.05	60.08	6.68	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	135.42	0.00	0.00	27.08	0.00	27.08
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	87.22	47.07	4.15	0.00	5.54	4.15
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	97.60	47.55	5.01	10.01	2.50	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	154.29	35.60	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	110.21	69.20	2.56	5.13	2.56	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	59.42	59.42	9.14	0.00	0.00	4.57
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	141.32	56.85	0.00	4.87	3.25	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	96.70	63.36	1.67	0.00	1.67	1.67
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	47.20	21.78	3.63	0.00	3.63	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	148.23	79.41	9.26	3.97	0.00	1.32
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	84.26	56.54	5.54	5.54	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	68.10	73.34	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	101.41	45.98	1.89	3.78	1.89	3.15
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	114.45	63.41	0.00	6.19	1.55	1.55
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	58.54	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	124.69	64.60	5.17	1.29	1.29	2.58
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	136.84	75.67	6.44	1.61	3.22	1.61
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	83.64	47.79	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	157.27	60.30	6.52	5.70	3.26	3.26
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	144.41	65.07	2.94	3.36	2.10	1.68
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	143.72	14.37	14.37	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	134.22	48.22	4.82	1.61	1.61	0.80
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	81.25	44.32	3.69	0.92	0.00	1.85
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	120.65	45.24	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	101.02	44.84	2.83	3.30	1.42	1.89
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	96.14	39.00	6.35	0.00	3.63	3.63
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	44.23	58.97	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	130.21	46.27	6.46	2.15	3.23	1.08
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	114.34	76.23	5.08	7.62	2.54	5.08
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	131.44	16.43	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	140.29	56.12	6.38	4.46	2.55	4.46
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	123.94	60.15	7.29	1.82	3.65	3.65
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	31.61	15.80	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	154.95	71.41	7.14	1.43	0.71	5.71
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	136.05	76.32	3.32	6.64	0.00	6.64
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	62.55	62.55	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	118.83	40.13	6.48	2.47	3.09	1.54
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	152.77	87.80	8.78	7.02	5.27	3.51
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	94.29	78.58	3.14	3.14	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	157.16	70.23	9.74	5.56	5.56	5.56
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	108.44	39.84	2.21	6.64	0.00	2.21
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	100.50	25.94	3.24	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	129.05	43.60	2.62	4.36	2.62	3.49
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	101.24	49.50	4.50	2.25	4.50	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	87.11	38.33	3.48	0.00	0.00	6.97
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	133.35	57.61	2.13	6.40	0.00	1.07
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	134.39	56.80	5.54	2.77	1.39	1.39
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	108.28	85.49	2.85	2.85	0.00	2.85
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	114.13	43.26	3.68	3.68	1.84	3.68
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	121.01	60.51	0.00	3.03	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	74.50	43.46	6.21	0.00	0.00	12.42
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	100.45	61.33	2.11	7.40	2.11	7.40
Keratinocyte - epidermal, donor1	11272-116H3	52.22	46.27	2.77	2.77	1.39	1.31
Keratinocyte - epidermal, donor2	11349-117G8	49.78	34.55	0.00	1.76	0.59	0.59
Keratinocyte - epidermal, donor3	11421-118F8	60.77	28.40	2.18	2.37	0.95	1.23
Keratinocyte - oral, donor1	11251-116E9	71.18	54.49	1.93	4.43	0.79	1.02
Keratocytes, donor1	11527-119I6	214.55	46.07	6.53	1.38	1.72	1.03
Keratocytes, donor2	11607-120I5	80.85	26.95	2.34	2.34	2.34	0.00
Keratocytes, donor3	11688-122I5	41.50	16.60	0.79	0.99	0.00	0.20
Krukenberg tumor cell line:HSKTC	10687-109F3	81.32	32.97	4.40	0.00	2.20	0.00
Lens Epithelial Cells, donor1	11529-119I8	36.68	18.34	0.00	1.08	2.16	0.00
Lens Epithelial Cells, donor2	11609-120I7	55.71	25.49	0.81	3.58	0.69	0.23
Lens Epithelial Cells, donor3	11690-122I7	47.83	20.99	2.22	2.62	0.91	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	52.06	29.53	2.49	2.37	0.59	0.47
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	34.88	17.02	2.51	2.51	0.28	0.28
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	45.81	22.67	1.42	1.89	0.63	0.94
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	32.26	15.06	2.69	1.08	0.00	0.54
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	47.91	21.12	3.15	0.95	0.32	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	40.97	17.03	2.16	2.05	0.65	0.86
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	30.37	18.06	1.23	2.05	0.41	0.82
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	41.46	22.00	0.51	2.78	0.00	1.01
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	44.05	22.38	2.11	2.67	0.42	0.14
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	29.66	23.34	0.79	1.58	0.40	0.79
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	41.69	21.71	1.36	2.71	0.19	0.39
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	40.73	20.37	1.30	2.22	0.37	0.56
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	31.36	19.86	2.09	2.09	0.70	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	38.40	22.66	1.19	2.62	0.24	0.48
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	41.75	20.33	1.37	2.47	0.69	0.96
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	29.56	27.41	1.23	1.54	0.00	1.23
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	36.79	17.46	1.25	2.18	0.94	0.62
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	46.48	26.35	2.74	3.29	0.55	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	29.62	16.46	0.99	2.30	0.99	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	41.88	25.77	1.46	4.69	0.29	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	45.55	26.88	1.49	2.99	0.25	0.50
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	28.13	16.49	0.97	0.97	0.48	0.97
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	40.66	24.78	2.96	2.69	0.27	0.54
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	42.54	20.89	1.67	3.18	0.61	1.06
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	22.81	18.14	1.04	1.04	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	43.97	28.06	2.93	3.14	0.21	0.63
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	41.35	18.20	2.26	2.11	0.75	0.45
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	32.33	28.20	2.75	2.75	0.00	2.06
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	38.01	25.40	1.13	2.45	0.00	0.38
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	47.08	19.72	2.97	2.44	0.53	1.06
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	31.50	26.17	0.48	1.94	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	47.63	24.81	1.32	1.65	0.33	0.33
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	42.87	18.21	2.48	1.86	1.61	0.62
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	38.50	22.21	0.00	1.48	1.48	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	35.58	22.98	0.74	1.48	1.24	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	37.81	16.09	2.06	2.06	0.55	1.24
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	31.52	19.30	1.93	2.57	0.96	0.32
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	50.82	29.52	0.61	3.04	0.91	0.30
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	38.21	18.06	1.40	1.96	0.28	0.14
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	37.69	13.87	1.07	1.42	1.07	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	46.05	24.72	1.45	3.39	0.48	0.97
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	43.57	20.23	2.49	2.18	0.93	0.31
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	34.38	25.07	1.43	2.15	0.36	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	54.23	31.03	1.31	3.27	0.98	0.65
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	35.55	16.01	1.65	0.71	0.24	0.94
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	55.44	33.29	1.11	1.98	0.50	0.50
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	45.85	25.87	1.28	2.05	0.51	0.51
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	32.82	22.97	0.60	1.49	1.19	1.19
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	65.71	45.32	6.80	4.53	6.80	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	59.84	48.33	3.84	2.30	1.53	3.07
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	53.44	31.17	4.45	4.45	2.97	0.74
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	75.32	55.43	5.50	4.23	2.96	3.39
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	54.86	49.23	2.81	3.52	4.22	1.41
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	45.76	51.37	1.87	6.54	2.80	0.93
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	53.07	50.50	7.21	3.61	3.09	7.73
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	46.39	46.39	4.76	3.57	2.38	2.38
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	65.82	41.39	5.65	3.17	2.49	0.45
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	53.80	48.28	6.11	3.78	2.91	2.62
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	66.18	53.12	3.60	2.25	3.15	0.90
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	106.36	67.20	6.91	4.61	3.25	2.44
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	71.38	64.70	5.14	4.11	3.59	2.57
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	53.99	40.58	5.65	3.88	2.12	1.41
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	43.98	34.65	2.67	4.00	2.00	2.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	71.31	63.16	3.06	4.08	2.55	2.04
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	68.57	49.89	4.80	5.07	3.47	3.47
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	69.34	52.53	5.10	2.46	3.59	2.27
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	78.54	56.45	3.68	4.91	1.84	3.68
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	105.19	61.97	8.97	4.08	6.52	4.08
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	82.46	48.52	6.87	4.37	3.12	2.71
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	74.55	50.73	4.48	3.36	1.96	3.36
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	72.12	56.67	5.15	7.21	10.30	4.12
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	75.77	54.87	7.55	4.64	2.32	4.35
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	75.63	41.55	5.08	3.89	3.59	1.20
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	68.60	52.56	3.87	2.77	2.77	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	95.80	81.66	9.90	4.95	5.30	4.60
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	77.08	56.42	7.01	4.43	4.06	3.69
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	52.96	59.87	3.45	4.61	1.15	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	94.02	68.69	6.91	6.14	2.30	1.92
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	97.94	66.80	7.36	4.53	2.83	2.83
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	76.30	46.77	2.46	4.92	4.10	0.82
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	96.70	65.97	6.33	6.33	4.97	4.97
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	77.56	64.63	3.59	3.59	2.15	3.59
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	69.46	56.76	5.23	2.99	5.23	3.73
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	89.18	85.84	14.12	7.43	3.72	6.32
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	60.74	47.38	4.74	5.60	3.88	2.15
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	69.36	63.37	1.71	1.71	4.28	3.43
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	74.63	55.97	6.33	5.00	2.33	3.66
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	80.84	54.90	4.83	4.22	3.02	0.60
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	73.23	54.04	6.40	2.84	2.13	1.42
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	83.18	55.34	7.56	5.84	3.09	3.44
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	68.17	60.12	6.44	3.22	2.15	2.15
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	57.91	45.79	6.73	4.04	0.67	1.35
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	78.53	63.71	5.56	2.96	3.33	4.44
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	63.96	50.01	3.49	1.16	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	57.12	41.25	4.23	3.17	2.12	1.06
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	80.03	56.82	8.80	3.60	2.40	3.20
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	69.05	45.07	5.81	2.18	1.45	2.18
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	82.02	48.29	9.96	4.60	4.60	1.53
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	80.90	68.57	5.92	5.43	1.97	5.43
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	71.51	65.87	0.94	8.47	2.82	3.76
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	72.41	59.33	5.53	3.52	4.02	2.01
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	88.32	63.99	4.06	7.66	3.15	3.60
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	65.40	72.29	5.16	0.00	0.00	3.44
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	81.50	62.79	5.34	4.01	4.90	5.79
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	85.63	72.34	7.04	4.30	2.74	1.96
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	61.36	65.31	1.98	5.94	1.98	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	62.79	67.98	4.15	4.67	2.08	1.56
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	96.26	85.33	10.50	7.44	5.69	3.50
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	74.36	66.53	6.15	4.47	2.24	5.03
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	83.47	62.27	5.74	3.97	3.53	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	99.51	67.50	8.49	4.63	1.93	2.70
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	86.59	64.31	5.57	3.04	2.53	2.03
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	86.99	63.44	7.69	4.81	2.40	2.88
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	89.45	69.17	7.55	4.77	4.77	3.18
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	96.00	72.91	4.25	6.08	2.43	3.04
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	47.04	45.65	4.84	1.38	2.08	2.08
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	102.22	74.10	6.46	4.94	3.80	3.42
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	108.96	80.04	5.68	3.61	2.58	1.55
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	57.44	58.05	8.47	6.05	2.42	1.81
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	101.09	72.89	6.65	4.75	3.80	3.17
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	100.75	77.83	5.86	5.33	3.73	1.60
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	66.09	49.42	6.32	3.45	1.15	1.72
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	109.53	99.25	9.77	7.20	4.63	3.60
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	103.27	80.64	7.07	9.20	4.95	7.07
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	72.64	53.91	13.05	5.11	3.97	5.11
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	114.41	79.04	7.07	3.33	3.74	7.07
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	104.93	97.10	8.61	3.13	2.35	5.48
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	64.30	56.37	11.27	3.76	2.92	2.09
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	101.29	86.89	5.58	4.65	4.65	4.18
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	80.29	84.30	8.70	3.35	2.01	4.68
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	74.85	65.76	11.23	3.74	2.67	1.60
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	107.09	99.00	8.49	5.25	7.27	3.64
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	93.61	67.00	5.51	6.42	1.84	2.75
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	72.02	47.12	13.34	3.56	1.78	6.22
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	127.08	77.50	5.70	4.56	2.28	2.28
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	95.10	74.39	6.90	3.83	3.07	2.30
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	70.04	56.36	11.49	2.74	1.09	1.64
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	109.13	65.04	8.46	3.56	4.01	5.79
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	115.42	74.61	9.62	2.08	3.12	2.08
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	59.02	46.42	6.63	3.32	1.99	2.65
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	112.24	60.28	10.39	4.16	2.08	2.08
Macrophage - monocyte derived, donor1	11232-116C8	40.57	25.53	3.42	2.73	1.14	0.00
Macrophage - monocyte derived, donor2	11313-117C8	34.32	22.75	4.59	1.65	1.28	0.55
Macrophage - monocyte derived, donor3	11389-118C3	53.35	22.41	6.55	1.97	1.84	0.26
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	25.49	11.15	1.59	0.00	0.53	0.00
Mallassez-derived cells, donor2	11929-125I3	32.96	38.82	2.06	1.58	1.11	0.63
Mallassez-derived cells, donor3	11930-125I4	39.19	36.69	2.50	1.53	0.83	0.69
Mammary Epithelial Cell, donor1	11273-116H4	42.15	21.52	2.29	1.20	0.80	0.50
Mammary Epithelial Cell, donor2	11350-117G9	44.59	17.08	2.03	1.74	1.45	1.16
Mammary Epithelial Cell, donor3	11422-118F9	85.55	19.70	4.49	1.50	1.50	0.25
Mast cell - stimulated, donor1	11487-119E2	246.09	130.16	10.17	6.10	1.36	1.36
Mast cell, donor1	11563-120D6	103.27	68.89	5.95	6.16	1.41	1.19
Mast cell, donor2	11565-120D8	154.23	199.70	6.54	17.24	2.67	0.89
Mast cell, donor3	11566-120D9	161.86	206.89	5.85	27.24	1.80	2.93
Mast cell, donor4	11567-120E1	150.34	175.16	6.91	17.91	1.60	1.77
Mast cell, expanded and stimulated, donor5	11940-126A5	75.41	78.73	3.33	5.66	1.66	0.78
Mast cell, expanded and stimulated, donor8	11942-126A7	96.31	43.19	2.92	1.75	2.92	1.17
Mast cell, expanded, donor5	11939-126A4	59.43	51.17	1.38	3.79	0.57	1.15
Mast cell, expanded, donor8	11941-126A6	76.99	38.66	3.35	6.36	0.67	0.33
Melanocyte - dark, donor1	11502-119F8	38.61	16.42	1.09	1.39	0.30	0.50
Melanocyte - dark, donor2	11582-120F7	31.49	13.84	2.08	0.35	0.00	0.00
Melanocyte - dark, donor3	11663-122F7	49.77	22.38	4.49	1.16	1.16	0.36
Melanocyte - light, donor1	11274-116H5	62.53	26.80	3.29	0.94	1.41	0.71
Melanocyte - light, donor2	11351-117H1	74.39	19.79	2.73	2.73	3.41	0.00
Melanocyte - light, donor3	11423-118G1	67.64	17.34	6.07	0.87	1.73	1.73
Melanocyte, donor1 (MC+1)	12641-134G4	43.11	23.12	2.50	0.83	0.42	0.42
Melanocyte, donor2 (MC+2)	12739-135I3	39.27	14.52	3.50	0.81	0.27	0.27
Melanocyte, donor3 (MC+3)	12837-137B2	42.32	23.84	2.95	1.07	0.80	0.80
Meningeal Cells, donor1	11493-119E8	122.32	41.31	6.08	4.34	1.36	1.36
Meningeal Cells, donor2	11573-120E7	92.87	29.05	6.60	3.08	2.20	2.64
Meningeal Cells, donor3	11654-122E7	74.25	34.15	3.26	2.45	1.30	0.98
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	51.33	13.69	2.85	1.71	0.57	0.00
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	42.77	16.91	1.81	1.61	0.40	0.20
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	68.34	31.54	1.31	1.31	0.00	0.00
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	88.95	32.70	5.23	0.00	2.62	1.31
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	46.64	13.63	2.15	0.72	1.44	0.00
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	35.37	22.45	0.42	1.69	1.27	0.00
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	35.19	17.59	3.02	3.52	0.00	1.01
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	85.92	35.60	3.30	3.96	1.32	0.88
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	107.40	37.99	11.69	0.00	6.58	1.46
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	81.43	33.35	4.09	2.46	1.23	0.82
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	32.13	8.59	1.52	3.05	0.28	0.28
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	78.43	26.39	1.86	0.74	1.12	0.74
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	54.08	29.21	0.92	2.89	0.79	0.53
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	54.01	20.77	0.59	2.97	0.30	0.00
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	46.71	35.03	0.00	2.34	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	71.72	21.13	1.28	2.56	0.00	0.00
Mesenchymal stem cells - adipose, donor0	11217-116B2	47.50	16.66	2.13	1.06	0.35	0.00
Mesenchymal stem cells - hepatic, donor0	11218-116B3	45.97	16.57	2.50	0.94	0.00	0.00
Mesenchymal stem cells - umbilical, donor0	11214-116A8	25.40	20.32	2.90	2.18	1.45	1.45
Mesothelial Cells, donor1	11247-116E5	37.92	14.58	1.59	1.33	0.80	0.53
Mesothelial Cells, donor2	12156-128G5	33.03	11.01	1.50	0.00	0.50	0.00
Mesothelial Cells, donor3	11402-118D7	41.48	16.04	1.95	1.52	0.51	0.79
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	117.48	29.71	8.10	2.70	4.05	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	50.98	27.83	3.94	3.20	2.46	0.74
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	48.29	25.03	7.66	2.36	1.77	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	110.63	24.20	10.37	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	30.68	14.88	3.10	1.24	1.55	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	31.32	18.67	4.36	0.62	0.62	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	97.27	20.84	16.21	2.32	2.32	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	36.54	22.77	5.51	1.50	2.00	0.25
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	47.94	23.27	4.19	2.79	0.93	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	116.80	58.40	19.47	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	29.26	25.61	2.85	1.42	0.61	1.42
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	45.14	24.55	6.73	2.38	2.38	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	128.27	25.65	17.10	0.00	8.55	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	16.81	23.01	1.77	1.77	3.54	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	26.60	17.10	3.04	0.76	1.90	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	98.69	14.47	7.90	1.32	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	27.16	23.13	1.70	0.85	1.06	0.42
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	42.36	21.18	4.60	0.00	0.92	0.92
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	30.70	22.35	3.28	1.49	1.49	1.19
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	72.10	28.50	5.03	3.35	1.68	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	237.65	33.95	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	22.83	22.58	4.01	2.26	0.75	0.75
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	27.81	15.69	4.52	0.71	0.71	0.24
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	62.48	19.90	5.53	1.66	0.55	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	15.43	20.72	1.15	0.92	0.92	0.46
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	34.71	15.78	3.79	1.26	1.05	0.42
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	23.85	23.85	2.65	1.02	1.63	0.20
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	20.81	15.02	2.57	0.64	0.64	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	29.79	16.89	3.78	2.00	1.56	0.22
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	72.23	10.32	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	22.56	13.58	0.88	1.10	0.44	0.22
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	44.11	8.11	4.06	1.01	0.51	0.51
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	74.56	9.94	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	30.44	22.02	1.09	1.90	0.54	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	34.11	14.70	2.35	1.18	1.47	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	57.79	11.99	1.09	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	19.22	14.90	0.48	1.44	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	22.81	20.41	3.60	1.60	1.20	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	47.99	19.20	6.86	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	20.52	20.02	0.50	0.50	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	0.00	0.00	0.00	53.89	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	40.77	14.27	4.08	0.00	4.08	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	14.45	22.33	1.31	0.44	0.44	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	26.49	12.14	1.10	1.10	1.10	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	49.95	17.29	2.56	1.28	1.92	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	18.84	22.81	1.24	2.23	0.25	0.25
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	35.49	9.05	2.78	0.70	2.09	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	110.49	24.31	4.42	0.00	2.21	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	19.83	18.80	0.68	1.03	1.03	0.34
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	40.70	16.63	2.63	1.75	0.44	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	88.77	17.40	10.30	1.42	1.42	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	26.93	23.57	2.52	0.84	1.12	0.28
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	38.24	14.13	6.65	0.42	0.42	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	78.09	28.55	8.16	1.75	0.58	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	31.67	30.47	3.92	2.11	1.21	0.60
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	35.06	16.28	2.92	0.83	0.42	1.25
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	79.41	50.53	14.44	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	44.33	22.17	2.77	0.92	2.77	0.92
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	46.10	21.06	9.11	1.71	2.28	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	60.11	28.33	7.19	0.83	0.97	0.28
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	28.25	20.47	2.59	1.30	0.26	1.04
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	45.90	30.46	6.01	1.72	2.14	0.43
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	67.97	26.04	3.18	0.00	2.54	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	36.83	31.76	1.87	2.67	0.80	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	30.23	34.12	2.10	2.99	0.60	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	44.78	24.44	3.96	1.27	0.57	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	19.11	22.93	0.96	1.27	0.32	0.32
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	35.38	29.41	4.64	1.99	1.33	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	68.26	30.34	6.45	1.52	0.76	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	25.57	29.55	3.13	1.99	0.28	0.28
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	37.36	31.22	3.44	0.49	1.23	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	48.88	29.98	2.61	0.65	1.30	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	25.87	33.81	1.18	1.76	0.88	0.59
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	27.68	28.54	2.59	0.86	0.58	0.00
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	40.80	38.74	1.24	0.00	0.41	0.00
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	27.10	27.40	2.08	1.19	0.60	0.30
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	18.83	0.00	3.77	3.77	3.77	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	10.69	14.26	1.78	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	38.11	22.01	3.94	0.66	1.31	0.66
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	16.83	12.62	3.16	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	29.46	14.83	2.17	0.79	1.58	0.40
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	39.12	23.28	2.79	1.86	0.93	0.93
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	35.68	17.27	3.38	1.50	0.75	1.13
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	18.91	12.78	2.13	1.86	0.53	0.27
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	21.94	20.13	1.02	1.24	0.68	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	25.05	18.42	2.21	0.74	0.74	0.74
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	40.31	20.89	3.30	0.37	0.00	0.37
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	18.67	23.33	4.67	3.11	0.00	3.11
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	27.26	21.38	1.60	0.00	1.07	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	7.73	23.18	0.00	3.86	3.86	3.86
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	34.34	21.21	1.01	0.00	2.02	1.01
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	28.67	17.71	4.22	1.69	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	17.71	5.45	1.36	1.36	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	13.35	7.63	0.00	0.64	0.64	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	7.29	9.72	0.00	0.81	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	24.17	13.59	0.00	0.00	0.00	1.51
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	57.10	34.26	0.00	0.00	5.71	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	52.20	39.15	9.79	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	33.27	28.51	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	75.29	25.10	0.00	0.00	0.00	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	28.22	18.31	0.65	1.72	0.43	0.65
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	39.72	17.25	0.00	1.05	0.00	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	33.37	8.68	3.34	0.67	0.00	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	44.24	10.85	1.25	2.09	0.00	0.42
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	46.20	45.06	4.56	3.23	1.52	1.14
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	156.39	14.36	4.79	1.60	3.19	0.00
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	21.08	10.20	0.00	1.36	0.00	0.00
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	51.45	45.94	9.19	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	19.67	7.12	1.26	2.93	0.00	0.42
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	26.96	12.78	3.49	0.70	0.23	0.23
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	38.10	10.00	1.08	1.62	0.27	0.00
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	59.50	20.39	2.73	1.47	0.21	0.21
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	22.27	66.81	11.13	0.00	11.13	0.00
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	33.75	8.44	0.99	0.99	0.00	0.50
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	19.76	13.26	1.62	1.35	0.27	0.27
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	23.57	8.39	1.59	1.59	0.23	0.68
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	40.17	15.51	1.96	0.82	0.00	0.33
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	59.42	17.50	1.64	2.19	0.55	0.91
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	34.48	12.73	2.12	2.12	0.00	0.00
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	39.02	9.00	0.60	1.80	0.00	1.20
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	32.49	35.77	1.97	3.61	0.00	1.31
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	22.44	8.13	1.95	0.98	0.98	0.98
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	71.43	19.93	1.59	1.94	0.53	0.00
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	26.72	7.03	3.52	2.11	0.00	0.00
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	34.94	11.95	2.30	2.76	0.92	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	41.13	10.93	1.61	1.29	0.32	0.32
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	25.87	32.76	3.45	2.76	1.38	0.34
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	134.01	93.55	7.59	2.53	0.00	0.00
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	80.43	17.82	1.56	1.78	0.45	0.22
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	26.25	11.43	2.12	1.69	0.85	0.85
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	25.63	19.23	1.19	0.71	0.95	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	34.34	11.16	0.43	0.43	0.00	0.43
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	126.39	108.33	9.03	9.03	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	43.65	10.33	1.67	0.33	0.00	1.00
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	68.98	19.39	1.80	2.25	1.35	0.00
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	25.79	11.11	1.19	0.40	1.19	0.79
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	37.15	3.71	0.93	0.93	0.00	0.93
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	31.78	14.00	1.14	1.14	0.00	1.14
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	31.94	10.43	0.98	0.33	0.00	0.33
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	59.27	12.64	1.31	0.44	0.00	0.87
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	61.51	21.26	1.36	1.36	0.00	0.45
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	15.87	14.11	0.00	1.76	0.88	0.00
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	31.91	7.98	1.33	1.99	0.66	0.66
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	37.70	10.91	0.50	1.98	0.50	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	35.99	12.25	1.15	0.77	0.77	0.38
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	34.78	26.62	2.12	0.30	0.30	1.21
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	45.31	21.00	2.21	2.43	0.44	0.22
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	24.40	12.20	0.68	0.68	0.00	0.00
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	61.31	56.20	10.22	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	35.97	9.75	0.61	1.22	0.61	0.61
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	37.77	9.44	0.94	1.57	0.31	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	35.41	18.16	1.51	3.63	0.30	0.61
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	24.53	9.49	0.00	0.79	2.37	1.58
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	37.41	54.41	9.07	3.40	0.00	0.00
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	40.46	50.58	0.00	5.06	0.00	10.12
Myoblast, donor1	11241-116D8	29.69	16.90	1.61	1.24	0.37	0.25
Myoblast, donor2	11322-117D8	63.87	16.88	3.26	0.77	0.58	0.77
Myoblast, donor3	11398-118D3	50.28	20.35	2.69	1.68	1.01	0.50
NK T cell leukemia cell line:KHYG-1	10777-110G3	135.57	52.54	6.42	1.61	1.31	0.88
Natural Killer Cells, donor1	11230-116C6	313.36	91.03	18.45	4.61	10.46	2.46
Natural Killer Cells, donor2	11311-117C6	293.41	111.27	19.30	3.62	7.54	1.51
Natural Killer Cells, donor3	11387-118C1	308.84	111.72	22.09	3.68	10.31	2.21
Neural stem cells, donor1	11275-116H6	139.73	65.33	8.35	2.54	4.72	1.45
Neural stem cells, donor2	11352-117H2	115.54	146.35	5.78	7.70	0.00	0.00
Neurons, donor1	11494-119E9	81.93	160.44	5.69	4.55	0.00	1.14
Neurons, donor2	11574-120E8	45.13	69.57	1.54	3.30	1.32	0.88
Neurons, donor3	11655-122E8	80.57	95.37	3.29	4.11	0.00	4.11
Neutrophils, donor1	11233-116C9	215.30	454.72	20.42	16.70	7.42	6.50
Neutrophils, donor2	11314-117C9	171.03	371.06	11.60	14.49	17.39	17.39
Neutrophils, donor3	11390-118C4	291.37	704.91	21.99	32.37	14.05	6.72
Nucleus Pulposus Cell, donor1	11252-116F1	64.00	22.08	1.42	3.68	0.47	1.42
Nucleus Pulposus Cell, donor2	11409-118E5	38.10	8.47	0.00	2.28	0.33	0.65
Nucleus Pulposus Cell, donor3	11462-119B4	32.69	7.62	1.60	1.20	0.20	0.40
Olfactory epithelial cells, donor1	11933-125I7	40.88	10.32	1.65	0.69	0.55	0.28
Olfactory epithelial cells, donor2	11934-125I8	43.28	15.92	2.75	0.72	0.87	1.88
Olfactory epithelial cells, donor3	11935-125I9	38.14	13.62	1.70	0.91	0.23	0.68
Olfactory epithelial cells, donor4	11936-126A1	62.24	17.73	2.92	1.75	0.39	0.58
Oligodendrocyte - precursors, donor1	11496-119F2	46.94	28.89	1.20	1.20	0.00	0.00
Osteoblast - differentiated, donor1	11276-116H7	59.55	29.78	2.13	2.55	1.49	0.00
Osteoblast - differentiated, donor2	11353-117H3	33.15	9.14	1.14	0.00	1.14	1.14
Osteoblast - differentiated, donor3	11425-118G3	40.97	9.31	1.24	0.00	0.00	0.00
Osteoblast, donor1	11277-116H8	81.11	31.27	2.35	2.74	0.78	0.20
Osteoblast, donor2	11354-117H4	58.29	31.60	1.40	2.81	0.70	1.40
Osteoblast, donor3	11426-118G4	95.80	25.77	2.49	2.13	1.60	0.71
Pancreatic stromal cells, donor1	11249-116E7	53.91	21.90	1.68	1.85	1.26	0.51
Pericytes, donor1	11491-119E6	50.40	28.26	2.00	3.89	0.67	0.89
Pericytes, donor2	11571-120E5	55.01	28.07	4.07	3.85	0.68	1.13
Pericytes, donor3	11652-122E5	67.55	29.09	2.44	2.64	1.02	1.02
Perineurial Cells, donor1	11499-119F5	44.19	26.45	1.47	1.47	0.00	0.45
Perineurial Cells, donor2	11579-120F4	48.12	15.55	1.66	1.47	0.74	0.09
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	335.95	126.22	19.44	5.10	7.33	3.51
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	233.84	114.60	11.75	5.63	6.61	1.47
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	254.69	122.94	14.37	5.69	5.44	1.42
Placental Epithelial Cells, donor1	11278-116H9	73.66	73.66	3.59	4.07	0.48	0.24
Placental Epithelial Cells, donor2	11355-117H5	37.70	24.40	0.00	3.33	0.00	1.11
Placental Epithelial Cells, donor3	11427-118G5	51.24	34.55	1.37	3.53	0.39	1.57
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	21.20	6.65	0.63	0.00	0.00	2.22
Preadipocyte - breast, donor1	11467-119B9	28.89	15.01	0.94	0.75	0.19	0.00
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	43.07	31.59	1.44	1.31	1.31	0.39
Preadipocyte - breast, donor2	11328-117E5	38.73	18.69	1.80	1.35	0.45	2.25
Preadipocyte - omental, donor1	11468-119C1	36.66	20.78	1.39	1.49	0.75	0.43
Preadipocyte - omental, donor2	11329-117E6	44.52	18.33	4.36	2.18	0.44	0.87
Preadipocyte - omental, donor3	11403-118D8	42.12	16.04	2.15	0.57	0.43	1.29
Preadipocyte - perirenal, donor1	11469-119C2	39.37	9.84	1.97	0.00	0.98	0.00
Preadipocyte - subcutaneous, donor1	11279-116I1	103.19	28.25	3.69	1.84	2.46	0.92
Preadipocyte - subcutaneous, donor2	11356-117H6	78.80	18.95	4.60	1.42	1.42	2.48
Preadipocyte - subcutaneous, donor3	11428-118G6	54.49	13.96	3.92	0.68	1.36	0.17
Preadipocyte - visceral, donor1	11280-116I2	81.78	22.63	3.91	2.05	1.77	0.93
Preadipocyte - visceral, donor2	11357-117H7	59.36	27.15	2.76	1.38	2.30	2.30
Preadipocyte - visceral, donor3	11429-118G7	50.89	10.03	3.97	0.73	0.73	0.94
Prostate Epithelial Cells (polarized), donor1	11253-116F2	95.49	73.16	5.88	3.32	2.72	2.11
Prostate Epithelial Cells, donor2	11331-117E8	28.98	26.41	1.49	1.22	0.54	1.35
Prostate Epithelial Cells, donor3	11404-118D9	25.35	61.18	0.67	3.43	0.18	0.80
Prostate Stromal Cells, donor1	11254-116F3	64.24	25.06	3.30	1.82	1.37	0.46
Prostate Stromal Cells, donor2	11332-117E9	70.29	23.67	3.59	1.43	1.79	1.79
Prostate Stromal Cells, donor3	11405-118E1	39.31	17.10	1.36	1.15	0.73	0.83
Renal Cortical Epithelial Cells, donor1	11516-119H4	66.79	47.45	2.92	3.28	0.36	0.00
Renal Cortical Epithelial Cells, donor2	11596-120H3	33.75	37.36	0.69	3.12	0.21	0.42
Renal Epithelial Cells, donor1	11517-119H5	106.52	63.91	3.55	2.54	1.01	1.52
Renal Epithelial Cells, donor2	11597-120H4	83.94	28.45	7.11	1.42	1.42	0.00
Renal Epithelial Cells, donor3	11678-122H4	49.65	41.82	1.48	3.92	0.32	0.32
Renal Glomerular Endothelial Cells, donor1	11514-119H2	61.28	12.26	6.13	0.68	0.00	0.00
Renal Glomerular Endothelial Cells, donor2	11594-120H1	59.57	15.63	3.77	1.48	1.35	0.54
Renal Glomerular Endothelial Cells, donor3	11675-122H1	58.39	24.64	4.00	1.55	1.11	0.89
Renal Glomerular Endothelial Cells, donor4	11783-124B1	75.86	40.59	2.66	3.99	2.00	0.67
Renal Mesangial Cells, donor1	11518-119H6	83.85	37.64	2.86	3.52	2.20	0.66
Renal Mesangial Cells, donor2	11598-120H5	78.37	29.47	3.76	1.25	0.00	0.63
Renal Mesangial Cells, donor3	11679-122H5	79.62	38.84	3.88	2.22	0.28	0.55
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	73.28	33.55	2.95	3.22	1.88	1.34
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	37.11	25.30	1.27	0.84	1.27	0.84
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	98.74	36.83	4.82	3.09	1.54	1.16
Retinal Pigment Epithelial Cells, donor0	11215-116A9	49.00	21.26	2.33	1.30	1.30	0.52
Retinal Pigment Epithelial Cells, donor1	11528-119I7	71.91	32.69	2.84	3.41	0.57	0.28
Retinal Pigment Epithelial Cells, donor2	11608-120I6	93.65	39.11	6.17	0.00	1.03	2.06
Retinal Pigment Epithelial Cells, donor3	11689-122I6	43.91	43.16	1.76	4.01	0.00	0.50
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	87.00	65.88	2.94	4.01	1.60	0.94
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	81.30	25.02	0.89	1.79	0.00	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	36.87	58.89	0.55	3.85	1.65	1.65
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	78.89	53.95	4.64	2.90	2.32	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	84.52	27.96	4.68	1.95	1.17	0.78
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	95.33	32.57	5.66	1.59	1.19	1.09
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	90.57	35.47	2.45	1.34	0.56	0.33
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	86.33	38.33	4.96	2.85	1.61	1.36
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	93.94	36.83	4.89	1.40	0.93	1.17
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	99.39	36.52	3.93	2.77	2.08	1.62
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	58.87	25.60	4.65	1.92	1.10	0.41
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	93.64	30.56	2.87	1.51	1.66	2.87
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	92.28	40.14	3.05	1.25	0.72	0.18
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	54.37	26.54	3.44	3.30	1.43	0.29
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	82.31	35.41	3.65	1.61	1.40	1.93
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	88.73	34.96	3.98	2.21	0.66	1.33
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	58.88	30.78	4.97	2.29	1.53	1.15
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	107.51	35.77	4.10	2.79	1.68	0.65
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	121.39	58.44	3.95	3.57	1.50	0.94
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	79.76	29.86	7.96	1.19	2.12	0.53
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	100.36	39.33	4.28	2.24	1.07	1.85
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	101.40	39.53	3.06	2.29	0.95	1.15
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	73.79	28.73	5.34	1.60	1.39	0.64
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	82.97	37.84	3.92	2.24	1.12	1.96
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	97.24	44.26	4.79	1.54	2.73	0.34
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	72.39	28.08	5.65	2.19	1.46	0.55
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	93.08	34.95	5.15	1.35	0.98	1.72
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	104.77	39.49	5.10	1.61	1.88	1.48
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	49.06	27.36	4.48	2.36	1.89	1.65
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	82.94	39.09	3.97	1.98	2.58	2.18
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	112.71	44.20	5.14	3.04	1.87	0.47
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	53.71	30.48	5.81	2.28	0.41	0.62
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	105.74	44.02	5.75	2.65	1.77	2.88
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	126.37	39.48	3.34	2.72	1.88	0.42
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	66.89	33.51	7.54	2.56	1.62	0.54
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	123.80	50.75	6.98	2.21	1.87	0.34
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	122.81	45.50	5.01	2.51	2.89	0.77
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	55.19	27.85	3.78	1.89	1.20	1.38
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	122.22	35.53	7.13	2.33	2.74	0.69
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	106.22	33.49	5.25	2.13	3.28	1.31
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	55.22	27.27	4.94	1.70	1.70	0.68
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	90.11	38.62	5.92	1.63	1.63	1.18
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	80.50	46.11	2.13	1.87	2.67	0.53
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	67.34	27.65	3.59	2.49	0.97	0.69
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	67.86	32.62	2.38	2.86	1.19	0.71
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	105.00	59.86	1.61	3.22	1.81	0.40
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	56.79	21.75	3.11	2.83	0.94	1.41
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	92.58	49.61	2.10	3.14	0.70	0.70
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	97.92	39.29	0.91	2.12	1.51	0.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	51.52	16.89	3.30	2.08	0.49	0.37
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	173.64	78.89	5.24	3.64	1.46	0.44
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	87.61	40.76	1.83	1.83	0.61	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	40.39	19.59	1.81	1.81	0.60	0.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	103.59	39.81	4.98	2.26	0.90	2.26
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	97.35	44.33	2.70	0.60	0.90	1.50
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	72.26	24.44	3.54	1.77	1.65	0.35
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	112.27	38.85	7.26	2.13	1.49	0.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	96.16	36.06	2.40	0.60	0.60	0.00
Schwann Cells, donor1	11498-119F4	92.72	22.76	3.57	3.39	2.07	0.94
Schwann Cells, donor2	11578-120F3	40.83	13.61	3.40	3.40	0.00	0.00
Schwann Cells, donor3	11659-122F3	39.43	16.65	1.97	1.53	0.44	0.66
Sebocyte, donor1	11220-116B5	160.50	75.04	8.22	5.48	2.19	1.10
Sebocyte, donor2	11301-117B5	76.75	53.77	4.14	1.38	0.46	4.60
Sebocyte, donor3	11378-118B1	63.28	32.15	1.65	2.47	0.62	0.62
Sertoli Cells, donor1	11255-116F4	59.64	29.82	1.66	0.00	0.00	0.00
Sertoli Cells, donor2	11333-117F1	36.72	36.72	2.82	2.82	0.00	0.00
Skeletal Muscle Cells, donor1	11281-116I3	83.14	33.17	2.64	3.52	0.62	0.88
Skeletal Muscle Cells, donor2	11358-117H8	72.28	19.52	1.45	4.34	0.00	0.72
Skeletal Muscle Cells, donor3	11430-118G8	153.00	50.16	5.02	0.84	1.67	0.84
Skeletal Muscle Cells, donor4	11451-119A2	75.41	13.51	2.67	1.41	0.63	0.47
Skeletal Muscle Cells, donor5	11455-119A6	74.47	15.76	4.46	1.04	1.34	0.59
Skeletal Muscle Cells, donor6	11459-119B1	92.80	16.47	6.31	2.31	0.62	0.31
Skeletal Muscle Satellite Cells, donor1	11240-116D7	74.97	22.68	1.76	1.64	0.13	0.13
Skeletal Muscle Satellite Cells, donor2	11321-117D7	80.90	18.98	2.43	1.43	0.57	0.71
Skeletal Muscle Satellite Cells, donor3	11397-118D2	102.09	24.70	5.06	1.49	1.29	1.09
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	65.63	28.56	3.79	1.85	0.84	0.76
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	105.67	28.23	3.62	3.62	0.00	0.00
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	63.85	15.41	3.44	0.96	1.38	0.96
Skin - palm, donor1	10286-104F7	228.32	53.72	10.74	0.00	5.37	0.00
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	23.07	19.03	1.15	1.87	1.01	0.14
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	55.62	61.34	3.27	4.09	0.00	0.82
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	30.38	15.32	1.69	1.04	0.52	0.78
Small Airway Epithelial Cells, donor1	11256-116F5	34.89	30.86	1.25	1.81	0.70	0.28
Small Airway Epithelial Cells, donor2	11334-117F2	43.32	33.76	2.39	2.25	0.84	0.70
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	108.05	60.68	4.02	3.17	1.27	0.21
Small Airway Epithelial Cells, donor3	11406-118E2	60.11	57.19	1.50	3.22	0.37	0.90
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	17.90	13.58	1.85	2.16	1.23	0.93
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	24.23	21.12	3.56	0.89	0.44	0.67
Smooth Muscle Cells - Aortic, donor0	11210-116A4	89.94	28.22	4.70	2.94	1.76	0.00
Smooth Muscle Cells - Aortic, donor1	11283-116I5	83.98	26.08	2.65	2.65	0.44	0.22
Smooth Muscle Cells - Aortic, donor2	11360-117I1	61.43	35.44	3.94	2.36	0.00	0.39
Smooth Muscle Cells - Aortic, donor3	11432-118H1	81.12	26.27	2.32	3.09	0.77	0.00
Smooth Muscle Cells - Bladder, donor1	11519-119H7	43.03	22.02	2.00	2.00	0.00	0.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	46.58	26.62	2.66	3.46	0.53	0.53
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	38.79	19.28	2.22	1.11	0.44	0.44
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	16.77	5.76	1.15	0.00	0.38	0.26
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	35.49	12.70	2.28	0.98	1.63	0.00
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	40.16	12.40	2.95	0.89	0.30	0.30
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	38.44	10.53	1.42	0.71	0.43	0.00
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	77.92	22.77	2.28	1.63	1.14	1.14
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	46.88	21.92	0.61	0.61	0.61	0.91
Smooth Muscle Cells - Carotid, donor1	11285-116I7	84.10	48.49	3.03	2.27	1.01	0.25
Smooth Muscle Cells - Carotid, donor2	11362-117I3	361.12	18.36	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	47.21	20.98	3.34	3.81	0.48	1.43
Smooth Muscle Cells - Colonic, donor1	11239-116D6	32.00	12.09	1.47	0.88	0.74	0.29
Smooth Muscle Cells - Colonic, donor2	11320-117D6	45.63	12.70	1.94	0.43	0.22	1.08
Smooth Muscle Cells - Colonic, donor3	11396-118D1	61.82	13.43	2.73	1.15	0.52	0.84
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	74.56	43.00	3.40	2.63	2.32	1.08
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	54.97	19.40	0.00	3.23	0.00	0.00
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	49.61	13.45	3.29	0.90	0.30	0.00
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	98.66	27.99	3.41	2.39	2.05	0.68
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	55.68	25.76	0.71	2.20	0.31	0.16
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	47.20	22.74	3.32	1.81	1.91	1.01
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	47.56	27.08	2.50	0.23	0.68	1.37
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	48.30	17.51	3.02	3.02	1.21	0.60
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	92.19	28.88	6.36	2.65	0.79	1.06
Smooth Muscle Cells - Prostate, donor1	11257-116F6	37.28	15.58	2.93	2.00	0.40	0.27
Smooth Muscle Cells - Prostate, donor2	11335-117F3	49.09	17.53	1.63	2.38	1.25	1.50
Smooth Muscle Cells - Prostate, donor3	11465-119B7	26.38	11.92	1.78	1.52	0.51	0.25
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	55.94	27.74	4.22	1.96	1.21	0.30
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	49.51	18.75	3.75	1.50	1.50	0.75
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	427.72	102.08	2.58	11.63	0.00	0.00
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	85.57	43.25	4.65	2.79	0.47	0.93
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	44.43	23.73	2.02	3.03	1.01	0.00
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	36.04	20.37	2.51	2.19	0.00	1.25
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	41.89	9.73	1.47	0.59	0.59	1.18
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	77.48	18.41	3.92	2.33	1.75	0.17
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	39.24	10.28	0.47	1.87	0.47	0.47
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	54.40	28.06	2.73	3.45	1.01	0.14
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	77.00	30.85	3.57	1.02	1.53	1.27
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	67.50	17.49	2.63	1.50	1.13	0.19
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	51.98	25.43	1.96	1.40	0.42	0.42
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	27.90	14.33	1.01	1.09	0.42	0.17
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	48.57	38.57	0.48	3.81	0.48	0.48
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	61.65	22.51	1.96	2.45	0.24	0.49
Smooth Muscle Cells - Uterine, donor1	11258-116F7	45.07	10.16	2.21	1.55	0.44	0.22
Smooth Muscle Cells - Uterine, donor3	11466-119B8	36.28	14.34	2.93	1.17	0.29	0.59
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	28.96	25.85	0.97	2.14	0.19	0.19
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	26.97	10.31	1.59	1.06	0.53	0.26
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	10.04	21.57	0.74	1.86	0.74	1.86
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	36.65	24.08	2.16	2.16	0.36	1.80
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	30.09	10.50	1.14	0.85	0.28	0.85
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	41.75	21.27	2.36	2.76	1.58	1.97
Smooth muscle cells - airway, control, donor1	11966-126D4	26.16	22.09	0.76	1.27	0.25	2.03
Smooth muscle cells - airway, control, donor2	11967-126D5	25.56	22.76	0.00	3.19	0.80	0.40
Smooth muscle cells - airway, control, donor3	11968-126D6	27.17	12.12	1.25	0.42	0.00	2.51
Smooth muscle cells - airway, control, donor4	11969-126D7	24.75	14.67	0.92	1.83	0.46	0.00
Synoviocyte, donor1	11291-117A4	48.48	39.22	1.85	1.85	0.84	1.18
Synoviocyte, donor2	11368-117I9	40.06	16.59	1.17	1.84	0.17	1.01
Synoviocyte, donor3	11440-118H9	35.08	10.05	1.56	1.12	0.45	0.45
Trabecular Meshwork Cells, donor1	11532-120A2	147.22	60.39	3.22	4.29	2.86	1.07
Trabecular Meshwork Cells, donor2	11612-122A1	126.85	31.71	5.95	0.00	3.96	0.00
Trabecular Meshwork Cells, donor3	11693-123A1	107.21	27.32	3.70	0.93	1.16	0.46
Tracheal Epithelial Cells, donor1	11292-117A5	61.00	38.64	2.58	2.44	0.72	0.50
Tracheal Epithelial Cells, donor2	11369-118A1	65.33	31.31	3.48	1.16	0.00	0.77
Tracheal Epithelial Cells, donor3	11441-118I1	57.27	17.75	8.02	2.29	0.57	0.57
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	86.36	60.04	3.32	3.57	0.98	0.74
Urethra, donor2	10319-105A4	196.03	120.49	3.60	3.60	1.80	0.00
Urothelial Cells, donor1	11520-119H8	32.15	44.63	1.33	2.13	0.00	1.06
Urothelial Cells, donor2	11600-120H7	38.45	32.05	1.20	3.61	1.60	0.80
Urothelial Cells, donor3	11681-122H7	44.92	40.34	0.69	3.21	0.92	0.69
Urothelial cells, donor0	11216-116B1	33.88	43.69	1.11	4.01	0.00	0.67
Whole blood (ribopure), donor090309, donation1	12179-129A1	69.40	102.33	5.34	6.23	1.78	0.89
Whole blood (ribopure), donor090309, donation2	12180-129A2	84.35	84.35	10.01	2.86	7.15	2.86
Whole blood (ribopure), donor090309, donation3	12181-129A3	84.20	121.16	4.79	2.74	4.79	3.42
Whole blood (ribopure), donor090325, donation1	12176-128I7	101.92	124.31	7.23	2.07	4.13	0.00
Whole blood (ribopure), donor090325, donation2	12177-128I8	108.65	128.41	5.23	4.07	2.32	0.58
Whole blood (ribopure), donor090612, donation1	12182-129A4	60.39	77.05	5.21	4.16	2.08	1.04
Whole blood (ribopure), donor090612, donation2	12183-129A5	51.40	81.68	3.67	2.75	1.84	0.92
Whole blood (ribopure), donor090612, donation3	12184-129A6	73.03	110.46	4.56	3.65	1.83	1.83
Wilms' tumor cell line:G-401	10809-111A8	108.56	16.04	8.27	1.60	3.82	0.99
Wilms' tumor cell line:HFWT	10597-108E3	183.05	22.00	3.52	1.76	1.76	0.00
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	91.34	53.35	2.51	5.03	1.40	0.28
achilles tendon, donor2	10292-104G4	146.72	47.53	2.07	0.00	0.00	4.13
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	142.01	31.87	7.14	0.76	2.80	2.04
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	198.97	54.56	6.50	2.55	2.79	1.39
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	274.45	62.80	9.26	3.21	4.63	1.31
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	119.19	47.08	11.16	2.72	4.63	0.82
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	138.57	35.70	7.31	2.25	2.53	1.97
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	85.02	36.59	3.81	1.48	0.63	0.21
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	96.09	66.15	2.72	5.72	1.63	2.18
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	121.62	44.50	2.20	3.97	0.44	0.44
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	129.45	67.38	5.31	2.04	2.04	2.45
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	210.85	27.18	12.81	0.78	4.27	1.55
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	80.78	31.83	5.52	1.10	2.94	0.74
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	444.66	39.01	7.80	3.90	0.00	3.90
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	129.67	26.49	8.60	1.86	5.81	1.16
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	165.70	98.90	6.21	6.21	3.88	2.33
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	153.14	46.76	8.18	1.17	2.34	2.05
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	120.37	50.19	7.90	0.93	4.18	0.46
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	97.06	52.64	4.52	0.41	0.41	1.65
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	130.45	27.93	9.21	2.46	4.30	1.53
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	146.36	37.55	9.81	1.28	1.71	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	140.73	42.46	8.80	1.21	2.73	1.82
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	161.51	40.20	6.98	2.89	3.61	1.20
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	104.46	40.32	4.23	2.90	3.56	1.11
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	115.07	83.72	5.67	1.33	2.00	0.33
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	204.40	40.88	7.43	0.00	0.00	0.00
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	96.05	57.25	4.90	2.26	3.01	1.51
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	184.48	57.57	5.23	2.18	1.74	0.87
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	260.55	41.24	7.50	0.00	3.75	0.00
adenocarcinoma cell line:IM95m	10796-110I4	113.51	15.07	5.42	0.71	1.41	0.24
adipose tissue, adult, pool1	10010-101C1	80.04	90.59	2.17	5.27	0.93	0.47
adipose, donor1	10184-103D4	143.67	148.36	7.04	13.49	1.76	1.17
adipose, donor2	10185-103D5	83.54	125.31	2.84	15.00	1.22	0.00
adipose, donor3	10186-103D6	143.22	88.49	5.17	7.62	1.63	0.82
adipose, donor4	10187-103D7	214.95	78.87	2.60	6.07	0.87	0.87
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	137.15	28.72	5.21	2.05	1.74	0.47
adrenal gland, adult, pool1	10081-102A9	50.93	47.29	3.64	0.00	7.28	0.00
adult T-cell leukemia cell line:ATN-1	10421-106C7	90.45	41.49	2.80	3.07	0.93	0.13
alveolar cell carcinoma cell line:SW 1573	10708-109H6	92.90	11.79	5.00	0.36	3.93	0.71
amniotic membrane cells, donor1	12235-129G3	35.24	50.54	2.09	3.25	0.70	0.00
amniotic membrane cells, donor2	12236-129G4	58.15	32.46	2.70	4.06	0.34	0.68
amniotic membrane cells, donor3	12237-129G5	21.80	69.82	1.47	5.30	0.88	0.00
amygdala - adult, donor10196	10167-103B5	49.80	37.95	4.74	1.19	8.30	1.19
amygdala, adult, donor10252	10151-102I7	87.60	106.25	6.08	6.29	3.85	0.81
amygdala, newborn, donor10223	10360-105E9	47.45	63.26	4.52	2.58	2.26	0.97
anaplastic carcinoma cell line:8305C	10428-106D5	80.85	61.50	1.53	5.86	0.76	1.53
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	110.97	43.46	3.75	1.54	0.88	0.66
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	274.58	27.06	10.36	2.00	4.01	1.00
aorta, adult, pool1	10052-101G7	94.14	54.92	2.16	2.94	0.98	0.98
appendix, adult	10189-103D9	177.37	90.82	11.26	3.88	3.88	2.72
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	112.47	40.24	3.10	1.03	1.03	0.34
artery, adult	10190-103E1	77.45	35.33	4.08	0.00	1.36	2.72
astrocytoma cell line:TM-31	10425-106D2	121.98	49.25	3.91	1.88	1.01	0.87
b cell line:RPMI1788	10427-106D4	129.52	30.19	1.78	4.31	1.34	1.19
basal cell carcinoma cell line:TE 354.T	10702-109G9	33.57	19.42	1.39	0.28	0.55	1.11
bile duct carcinoma cell line:HuCCT1	10432-106D9	82.66	51.10	5.76	3.37	2.68	0.79
bile duct carcinoma cell line:TFK-1	10496-107C1	64.44	52.72	2.68	2.34	1.17	0.84
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	91.16	39.15	2.24	3.91	3.91	0.00
bladder, adult, pool1	10011-101C2	89.52	70.83	2.28	3.59	0.65	0.22
blood, adult, pool1	10053-101G8	77.51	48.72	6.64	4.43	2.21	0.00
bone marrow stromal cell line:StromaNKtert	10686-109F2	69.36	20.55	3.43	0.86	0.00	0.00
bone marrow, adult	10192-103E3	70.86	68.83	4.72	2.70	2.02	2.02
brain, adult, donor1	10084-102B3	62.53	55.35	3.08	5.13	4.10	1.03
brain, adult, pool1	10012-101C3	72.05	58.91	5.79	3.45	5.01	1.11
brain, fetal, pool1	10085-102B4	101.51	50.76	13.36	5.34	2.67	2.67
breast carcinoma cell line:MCF7	10482-107A5	130.82	93.16	7.27	4.63	2.31	0.00
breast carcinoma cell line:MDA-MB-453	10419-106C5	105.60	101.98	5.12	5.37	1.50	0.75
breast, adult, donor1	10080-102A8	58.72	62.50	2.53	2.53	0.00	0.63
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	90.83	8.13	2.16	1.40	3.56	1.40
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	142.86	36.80	4.33	1.55	2.78	0.62
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	74.13	14.96	5.76	1.38	1.61	1.84
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	76.74	16.95	7.75	0.48	3.87	0.24
carcinoid cell line:NCI-H1770	10703-109H1	110.49	59.24	1.88	4.23	0.94	2.35
carcinoid cell line:NCI-H727	10735-110B6	189.23	84.88	12.80	4.70	3.72	0.66
carcinoid cell line:SK-PN-DW	10719-109I8	66.87	16.80	3.49	0.00	0.63	1.27
carcinosarcoma cell line:JHUCS-1	10642-109A3	207.09	48.44	7.19	1.86	2.66	2.93
caudate nucleus - adult, donor10196	10177-103C6	64.47	55.26	9.21	0.00	4.61	3.45
caudate nucleus, adult, donor10252	10164-103B2	94.54	76.47	9.37	2.68	6.69	1.34
caudate nucleus, adult, donor10258	10379-105H1	101.63	36.68	10.70	1.53	3.82	1.53
caudate nucleus, newborn, donor10223	10354-105E3	75.81	81.30	5.49	3.66	4.03	0.73
cerebellum - adult, donor10196	10173-103C2	107.79	96.14	8.74	5.83	8.74	0.00
cerebellum, adult, donor10252	10166-103B4	177.43	231.87	7.47	8.97	3.42	3.20
cerebellum, adult, pool1	10083-102B2	112.45	46.22	11.73	3.10	2.76	0.69
cerebellum, newborn, donor10223	10357-105E6	146.96	214.21	1.66	6.64	1.66	2.49
cerebral meninges, adult	10188-103D8	89.76	44.88	9.58	2.27	5.55	0.76
cerebrospinal fluid, donor2	10294-104G6	67.24	25.58	2.92	1.46	0.73	0.00
cervical cancer cell line:D98-AH2	10552-107I3	77.07	62.98	2.30	2.44	1.29	0.29
cervical cancer cell line:ME-180	10553-107I4	84.68	68.77	3.98	3.48	1.66	0.66
cervix, adult, pool1	10013-101C4	113.91	123.89	2.83	8.71	1.05	1.57
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	48.21	29.82	2.79	1.11	0.84	0.56
chondrosarcoma cell line:SW 1353	10700-109G7	117.56	7.84	0.00	0.00	0.00	0.00
choriocarcinoma cell line:BeWo	10423-106C9	114.96	72.58	1.99	6.21	0.50	1.12
choriocarcinoma cell line:SCH	10785-110H2	95.98	33.39	2.09	2.96	0.49	0.25
choriocarcinoma cell line:T3M-3	10618-108G6	75.90	67.36	0.47	7.83	0.00	0.00
chorionic membrane cells, donor1	12238-129G6	29.92	39.60	1.42	1.99	0.57	0.28
chorionic membrane cells, donor2	12239-129G7	49.22	25.95	1.99	1.39	0.89	0.20
chorionic membrane cells, donor3	12240-129G8	37.36	43.41	1.10	4.40	0.00	0.00
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	85.83	27.26	6.06	1.01	4.04	4.04
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	126.21	33.81	4.61	0.96	2.50	0.77
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	202.74	43.08	8.87	1.27	3.38	0.21
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	86.54	47.51	2.05	2.31	1.54	1.03
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	96.51	53.94	2.42	2.90	2.42	0.73
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	94.68	58.84	3.26	3.05	3.26	2.24
chronic myelogenous leukemia cell line:K562	10454-106G4	159.30	46.23	3.83	1.18	1.77	0.59
chronic myelogenous leukemia cell line:KU812	10409-106B4	285.38	98.00	10.69	2.87	3.13	1.56
clear cell carcinoma cell line:JHOC-5	10638-108I8	66.97	18.52	2.29	0.91	1.37	1.83
clear cell carcinoma cell line:TEN	10636-108I6	66.28	52.75	2.78	3.30	1.74	0.69
colon carcinoma cell line:CACO-2	10513-107D9	86.21	22.51	6.04	0.92	3.48	0.73
colon carcinoma cell line:COLO-320	10420-106C6	201.06	49.79	4.94	3.04	1.14	2.28
colon, adult, donor1	10082-102B1	126.14	51.17	1.19	7.14	1.19	0.00
colon, adult, pool1	10014-101C5	112.92	58.75	2.94	4.35	0.82	0.71
colon, fetal, donor1	10070-101I7	74.16	32.14	3.71	3.71	0.62	0.62
common myeloid progenitor CMP, donor1	12130-128D6	1365.89	357.51	0.00	18.33	4.58	0.00
common myeloid progenitor CMP, donor2	12134-128E1	25.04	0.00	0.00	0.00	0.00	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	210.77	35.69	8.92	0.85	4.25	0.85
cord blood derived cell line:COBL-a 24h infection	10453-106G3	119.39	17.51	7.55	0.45	2.72	0.75
cord blood derived cell line:COBL-a untreated	10449-106F8	138.47	21.29	9.73	0.71	5.22	0.56
corpus callosum, adult, pool1	10042-101F6	137.43	173.03	7.08	7.52	1.88	0.88
cruciate ligament, donor2	10295-104G7	149.13	61.60	3.24	4.05	0.00	0.00
diaphragm, fetal, donor1	10069-101I6	79.45	45.75	0.80	3.21	0.00	0.80
diencephalon, adult	10193-103E4	49.92	41.04	4.32	3.36	3.36	0.72
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	173.82	37.20	8.50	1.38	2.98	4.36
ductal cell carcinoma cell line:KLM-1	10438-106E6	186.69	70.01	5.90	2.56	2.31	0.26
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	74.14	24.07	2.65	2.65	0.96	0.96
ductus deferens, adult	10196-103E7	113.62	65.28	8.47	4.98	2.99	1.00
duodenum, fetal, donor1, tech_rep1	10071-101I8	80.65	53.29	0.00	1.44	0.00	1.44
duodenum, fetal, donor1, tech_rep2	10071-101I8	92.69	91.22	0.74	4.41	4.41	1.47
dura mater, adult, donor1	10041-101F5	126.44	49.39	4.87	5.45	1.82	0.58
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	184.99	94.60	7.99	3.33	2.44	1.55
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	118.22	47.57	3.73	3.01	2.29	0.57
embryonic pancreas cell line:1B2C6	10604-108F1	122.71	28.36	2.47	1.23	1.23	0.00
embryonic pancreas cell line:1C3D3	10605-108F2	84.15	16.95	1.51	0.61	0.61	0.61
embryonic pancreas cell line:1C3IKEI	10606-108F3	123.81	26.55	2.47	1.23	0.00	0.00
embryonic pancreas cell line:2C6	10603-108E9	143.17	34.15	3.94	0.00	2.63	0.00
endometrial carcinoma cell line:OMC-2	10497-107C2	82.46	19.78	3.02	1.34	2.01	0.67
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	87.17	23.20	3.08	1.45	1.45	0.54
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	32.00	47.44	2.09	1.29	0.32	2.09
epidermoid carcinoma cell line:A431	10426-106D3	108.05	63.69	4.34	3.78	1.56	0.44
epidermoid carcinoma cell line:Ca Ski	10431-106D8	116.58	57.08	8.14	1.76	2.20	1.21
epididymis, adult	10197-103E8	118.68	73.68	6.49	2.93	0.84	1.05
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	75.22	14.73	4.44	0.35	1.06	0.71
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	97.92	7.08	5.90	0.79	2.75	0.39
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	117.29	34.73	5.64	1.57	3.01	2.62
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	76.77	24.31	4.72	1.28	2.17	1.38
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	131.75	35.63	8.29	1.79	4.37	1.79
esophagus, adult, pool1	10015-101C6	71.67	43.21	3.40	2.44	1.06	0.85
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	175.21	51.10	8.52	4.13	3.01	0.88
eye - muscle inferior rectus, donor1	10272-104E2	125.56	55.54	2.41	2.41	2.41	0.00
eye - muscle lateral, donor2	10298-104H1	103.11	29.46	0.00	2.10	0.00	0.00
eye - muscle medial, donor2	10299-104H2	102.69	13.39	1.49	0.00	0.00	0.00
eye - muscle superior, donor2	10297-104G9	97.45	45.86	1.15	1.15	0.00	0.00
eye - vitreous humor, donor1	10268-104D7	107.85	29.15	10.20	0.00	7.29	0.00
eye, fetal, donor1	10054-101G9	55.17	61.78	2.54	4.32	1.02	1.02
fibrosarcoma cell line:HT-1080	10758-110E2	75.78	18.98	3.21	0.51	1.41	0.51
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	122.03	28.97	7.83	1.19	2.61	0.24
frontal lobe, adult, pool1	10040-101F4	87.73	74.59	7.51	2.63	5.82	0.19
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	125.50	47.44	5.40	0.30	2.40	1.20
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	59.89	43.43	1.74	2.83	0.82	0.46
gall bladder, adult	10198-103E9	95.37	92.71	5.79	5.07	0.72	0.97
gamma delta positive T cells, donor1	11937-126A2	154.61	53.69	6.44	3.22	4.29	1.61
gamma delta positive T cells, donor2	11938-126A3	116.16	36.23	10.46	2.24	6.35	0.37
gastric adenocarcinoma cell line:MKN1	10614-108G2	75.83	28.73	3.59	2.11	2.53	2.32
gastric adenocarcinoma cell line:MKN45	10612-108F9	138.68	43.33	4.06	2.71	3.09	0.77
gastric cancer cell line:AZ521	10549-107H9	123.62	34.27	5.74	1.80	2.95	0.98
gastric cancer cell line:GSS	10560-108A2	132.71	52.17	4.58	5.49	0.92	0.00
gastrointestinal carcinoma cell line:ECC12	10615-108G3	111.49	74.71	5.25	4.34	0.46	2.28
giant cell carcinoma cell line:LU65	10487-107B1	37.75	92.14	0.92	2.75	0.11	0.80
giant cell carcinoma cell line:Lu99B	10433-106E1	109.59	48.43	2.10	3.78	0.98	0.98
glassy cell carcinoma cell line:HOKUG	10688-109F4	112.49	33.67	8.73	1.75	1.50	0.50
glioblastoma cell line:A172, tech_rep1	10444-106F3	75.15	28.82	4.54	1.16	2.01	0.21
glioblastoma cell line:A172, tech_rep2	10444-106F3	80.05	26.82	4.77	1.26	1.69	0.56
glioblastoma cell line:T98G	10485-107A8	87.75	15.89	4.30	1.88	1.66	0.55
glioma cell line:GI-1	10413-106B8	100.16	52.43	2.64	2.64	0.88	0.88
globus pallidus - adult, donor10196	10175-103C4	59.04	54.67	5.10	0.00	2.92	0.73
globus pallidus, adult, donor10252	10161-103A8	117.65	140.84	5.86	5.37	2.69	1.46
globus pallidus, adult, donor10258	10367-105F7	75.31	68.46	4.11	4.11	5.48	1.37
globus pallidus, newborn, donor10223	10364-105F4	53.82	65.02	1.60	3.73	2.13	0.53
granulocyte macrophage progenitor, donor1	12131-128D7	1155.05	210.45	19.58	7.34	9.79	0.00
granulocyte macrophage progenitor, donor2	12135-128E2	109.28	43.71	21.86	10.93	0.00	0.00
granulocyte macrophage progenitor, donor3	12139-128E6	67.95	20.91	10.45	0.00	0.00	0.00
granulosa cell tumor cell line:KGN	10624-108H3	62.08	19.84	2.88	0.00	0.64	1.92
hIPS +CCl2, biol_rep1	14383-156B9	50.50	53.26	0.92	4.13	0.46	0.92
hIPS +CCl2, biol_rep2	14384-156C1	35.67	53.04	1.37	1.83	0.91	1.37
hIPS +CCl2, biol_rep3	14385-156C2	43.15	44.44	0.00	4.51	0.00	0.00
hIPS, biol_rep1	14380-156B6	34.49	61.80	0.00	0.00	0.00	0.00
hIPS, biol_rep2	14381-156B7	45.27	34.98	1.37	1.37	1.37	0.00
hIPS, biol_rep3	14382-156B8	46.35	45.24	3.31	1.10	3.31	1.10
hairy cell leukemia cell line:Mo	10712-109I1	110.91	18.96	4.02	2.30	2.59	1.15
heart - mitral valve, adult	10205-103F7	111.51	50.53	4.78	2.69	0.30	0.60
heart - pulmonic valve, adult	10206-103F8	111.13	64.32	5.75	3.14	1.05	0.52
heart - tricuspid valve, adult	10207-103F9	184.85	92.42	5.83	5.83	0.00	1.67
heart, adult, diseased post-infarction, donor1	10050-101G5	72.24	27.96	4.08	2.65	0.00	1.43
heart, adult, diseased, donor1	10051-101G6	68.56	57.06	2.55	1.28	0.85	0.00
heart, adult, pool1	10016-101C7	83.71	47.61	1.38	0.46	0.92	0.23
heart, fetal, pool1	10046-101G1	119.93	101.24	2.67	6.06	0.62	0.51
hepatic mesenchymal tumor cell line:LI90	10778-110G4	49.36	18.51	0.93	1.23	0.00	0.62
hepatoblastoma cell line:HuH-6	10633-108I3	372.21	40.43	13.08	0.00	3.57	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	148.29	59.45	8.07	2.98	2.54	1.99
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	148.20	51.83	8.25	1.94	4.13	2.31
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	155.72	65.99	9.09	1.82	2.63	1.52
hepatoma cell line:Li-7	10484-107A7	98.87	50.49	3.56	1.56	1.00	0.67
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	120.20	23.52	6.63	1.31	2.01	0.80
hippocampus - adult, donor10196	10169-103B7	45.42	46.37	7.57	0.95	5.68	0.95
hippocampus, adult, donor10252	10153-102I9	93.48	114.09	7.14	7.14	5.31	1.02
hippocampus, adult, donor10258	10374-105G5	37.84	48.30	1.99	2.49	6.47	1.00
hippocampus, newborn, donor10223	10363-105F3	56.04	47.94	3.17	2.11	2.47	0.35
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	67.14	95.82	0.61	7.32	0.00	1.83
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	75.79	68.53	1.77	5.69	0.79	1.37
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	77.69	73.63	1.52	3.55	0.76	1.02
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	98.68	106.57	1.69	11.28	0.56	0.56
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	113.61	100.96	3.36	10.07	0.77	4.65
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	109.71	97.94	2.28	8.35	0.38	1.14
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	164.95	109.77	9.63	7.59	2.63	1.75
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	162.22	104.05	6.89	10.56	3.02	4.74
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	174.75	74.24	7.51	7.92	4.17	0.83
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	113.19	49.49	4.03	3.55	1.18	0.95
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	157.34	79.72	6.27	4.66	2.41	2.89
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	119.85	48.48	5.39	4.71	3.37	0.67
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	76.99	65.72	1.72	5.63	0.94	0.63
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	56.99	56.50	1.97	6.88	0.98	1.97
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	53.24	94.26	0.87	8.73	0.00	0.87
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	141.46	116.65	2.67	8.40	0.76	0.19
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	107.27	105.97	3.05	4.80	0.00	0.87
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	102.45	142.93	2.00	11.49	0.50	1.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	83.83	117.18	2.07	12.06	0.57	0.94
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	78.67	116.41	2.27	12.73	1.36	1.82
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	67.03	136.26	3.13	17.23	0.63	0.94
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	81.32	65.65	4.41	3.27	1.63	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	74.90	52.26	4.35	4.35	1.45	1.45
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	80.71	85.79	3.59	4.48	1.20	1.49
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	82.58	81.29	1.29	4.43	1.11	3.14
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	83.87	60.77	1.43	5.71	2.00	1.43
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	100.44	83.30	6.94	6.94	1.22	1.22
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	104.22	94.01	3.87	5.99	0.70	3.87
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	94.39	95.97	4.12	6.65	1.27	2.22
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	109.85	103.80	3.03	5.75	0.30	0.61
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	104.46	77.05	5.17	4.14	2.59	2.59
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	89.00	79.70	3.98	9.30	2.66	1.33
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	113.90	64.65	5.39	5.64	1.54	0.51
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	90.76	43.97	5.62	3.83	2.81	3.32
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	110.55	51.49	2.27	6.06	1.51	2.27
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	80.65	51.08	4.37	3.36	0.67	1.68
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	80.66	81.15	2.66	4.59	0.97	1.21
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	79.33	82.00	3.12	5.79	0.00	0.45
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	89.27	86.83	2.44	3.90	1.46	3.41
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	142.11	112.47	2.75	9.47	2.44	2.14
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	175.68	312.31	3.25	22.77	6.51	6.51
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	122.78	146.28	3.97	10.92	0.66	5.96
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	124.78	91.40	3.28	10.95	1.64	3.28
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	111.10	77.81	4.34	9.77	1.45	1.09
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	104.27	77.94	4.63	6.41	0.36	2.49
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	108.60	60.86	2.39	2.39	1.19	3.58
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	119.31	68.39	6.77	4.88	2.57	1.35
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	91.32	52.26	3.50	3.50	1.89	1.62
immature langerhans cells, donor1	11904-125F5	105.09	49.40	2.91	3.63	2.91	0.24
immature langerhans cells, donor2	11905-125F6	125.16	93.47	7.92	7.13	1.58	2.38
insula, adult, pool1	10039-101F3	113.75	91.51	9.65	3.31	7.10	0.47
keratoacanthoma cell line:HKA-1	10791-110H8	65.03	13.66	0.98	0.33	0.33	0.33
kidney, adult, pool1	10017-101C8	75.90	56.97	3.70	1.80	0.50	0.20
kidney, fetal, pool1	10045-101F9	111.76	122.87	3.68	7.64	1.13	0.50
large cell lung carcinoma cell line:IA-LM	10509-107D5	174.26	54.54	7.24	2.56	2.27	1.28
large cell lung carcinoma cell line:NCI-H460	10839-111E2	43.82	15.90	2.07	0.97	0.55	0.55
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	78.35	42.39	3.12	3.30	0.55	0.18
left atrium, adult, donor1	10079-102A7	40.32	23.97	3.81	0.00	0.54	0.54
left ventricle, adult, donor1	10078-102A6	43.49	24.27	3.03	1.01	1.01	1.01
leiomyoblastoma cell line:G-402	10721-110A1	169.09	16.69	13.13	0.55	3.83	0.55
leiomyoma cell line:10964C	10569-108B2	26.58	13.65	2.16	1.44	1.08	0.36
leiomyoma cell line:15242A	10570-108B3	30.43	7.61	1.09	1.09	1.09	0.54
leiomyoma cell line:15425	10571-108B4	37.15	17.24	3.16	2.91	1.46	0.97
leiomyosarcoma cell line:Hs 5.T	10722-110A2	31.75	31.75	6.35	0.00	0.00	0.00
lens epithelial cell line:SRA 01/04	10647-109A8	94.10	52.28	6.27	0.00	3.14	2.09
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	145.80	57.61	4.60	1.42	2.72	0.35
liposarcoma cell line:KMLS-1	10782-110G8	50.30	19.99	2.34	0.62	0.78	0.31
liposarcoma cell line:SW 872	10726-110A6	105.51	14.74	5.12	0.73	1.83	0.73
liver, adult, pool1	10018-101C9	75.36	49.27	1.62	2.59	1.62	0.49
liver, fetal, pool1	10086-102B5	37.63	40.45	0.00	0.00	0.00	0.00
locus coeruleus - adult, donor10196	10182-103D2	91.87	46.81	7.73	1.17	2.19	0.29
locus coeruleus, adult, donor10252	10165-103B3	80.46	96.34	2.77	4.98	1.85	0.74
locus coeruleus, adult, donor10258	10375-105G6	35.27	28.21	5.08	1.97	1.69	2.54
locus coeruleus, newborn, donor10223	10362-105F2	60.99	129.13	4.63	5.05	4.21	2.10
lung adenocarcinoma cell line:A549	10499-107C4	59.37	17.44	2.91	1.94	1.25	0.42
lung adenocarcinoma cell line:PC-14	10408-106B3	113.06	37.23	8.27	2.76	3.45	0.00
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	125.75	39.81	8.30	2.77	3.16	0.66
lung, adult, pool1	10019-101D1	66.98	64.26	1.65	3.54	1.06	0.95
lung, fetal, donor1	10068-101I5	100.75	131.00	4.28	15.13	0.86	2.57
lung, right lower lobe, adult, donor1	10075-102A3	70.57	127.84	5.04	6.87	0.92	1.37
lymph node, adult, donor1	10077-102A5	89.94	49.70	3.79	4.73	0.47	0.47
lymphangiectasia cell line:DS-1	10727-110A7	101.26	35.29	2.85	3.29	0.44	0.44
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	137.49	47.69	5.74	2.11	3.47	0.45
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	139.32	174.15	4.25	3.40	5.95	0.85
mature adipocyte, donor1	12231-129F8	121.65	54.61	5.77	4.88	2.22	0.00
mature adipocyte, donor2	12232-129F9	92.14	64.96	2.91	2.49	1.87	0.00
mature adipocyte, donor3	12233-129G1	93.88	43.62	2.61	4.03	1.66	0.00
mature adipocyte, donor4	12234-129G2	117.39	53.70	3.95	5.53	2.11	0.79
maxillary sinus tumor cell line:HSQ-89	10414-106B9	135.57	127.71	5.72	9.29	3.57	0.95
medial frontal gyrus - adult, donor10196	10170-103B8	62.04	34.97	5.64	0.00	6.77	0.00
medial frontal gyrus, adult, donor10252	10150-102I6	99.68	101.70	6.80	4.97	4.97	0.55
medial frontal gyrus, adult, donor10258	10368-105F8	41.30	27.64	3.18	0.95	5.72	0.64
medial frontal gyrus, newborn, donor10223	10352-105E1	50.75	68.24	8.10	1.28	4.26	0.85
medial temporal gyrus - adult, donor10196	10183-103D3	82.35	50.79	7.09	1.69	4.56	3.54
medial temporal gyrus, adult, donor10252	10156-103A3	104.84	109.08	4.46	5.09	7.64	1.49
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	32.75	25.04	1.93	0.00	1.93	0.00
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	71.77	229.66	57.41	0.00	0.00	0.00
medial temporal gyrus, newborn, donor10223	10353-105E2	37.69	62.81	5.03	2.51	4.67	0.72
medulla oblongata - adult, donor10196	10174-103C3	70.74	38.94	3.24	1.30	1.30	0.00
medulla oblongata, adult, donor10252	10155-103A2	101.86	109.29	4.33	5.88	1.70	1.24
medulla oblongata, adult, pool1	10038-101F2	118.77	84.65	7.84	4.57	3.43	0.49
medulla oblongata, newborn, donor10223	10361-105F1	59.72	106.93	3.82	6.60	1.04	0.00
medulloblastoma cell line:D283 Med	10838-111E1	205.47	66.20	2.21	6.64	0.89	3.32
medulloblastoma cell line:ONS-76	10759-110E3	98.55	29.10	4.16	0.98	2.57	0.24
melanoma cell line:COLO 679	10514-107E1	75.90	26.88	3.88	1.72	1.58	0.43
melanoma cell line:G-361	10465-106H6	73.57	32.03	3.53	3.80	1.90	1.09
meningioma cell line:HKBMM	10691-109F7	32.02	29.13	0.72	1.63	0.72	0.54
merkel cell carcinoma cell line:MKL-1	10843-111E6	274.04	75.78	8.81	1.76	3.52	2.64
merkel cell carcinoma cell line:MS-1	10844-111E7	223.71	60.14	6.74	2.33	2.33	0.78
mesenchymal precursor cell - adipose, donor1	11747-123G1	58.92	13.81	4.60	1.07	1.99	0.92
mesenchymal precursor cell - adipose, donor2	11748-123G2	41.26	8.91	3.27	0.91	0.36	0.36
mesenchymal precursor cell - adipose, donor3	11749-123G3	25.26	7.04	3.31	1.66	0.41	0.41
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	31.61	9.41	3.65	0.98	0.84	0.42
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	38.71	7.13	2.89	0.19	0.39	0.00
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	38.17	14.58	2.78	2.78	1.39	0.00
mesenchymal precursor cell - cardiac, donor1	11752-123G6	35.70	12.87	2.40	1.54	0.51	0.69
mesenchymal precursor cell - cardiac, donor2	11753-123G7	42.21	12.42	4.72	1.61	0.69	0.12
mesenchymal precursor cell - cardiac, donor3	11754-123G8	44.83	12.07	4.51	0.93	0.80	0.93
mesenchymal precursor cell - cardiac, donor4	11755-123G9	35.11	12.42	3.24	1.62	0.95	0.41
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	46.66	14.23	2.28	1.14	0.57	0.14
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	28.98	21.08	1.32	4.61	0.99	0.33
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	48.71	16.60	3.60	1.11	0.42	0.55
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	41.19	10.82	2.09	0.35	0.70	0.70
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	24.50	9.19	1.63	1.22	0.20	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	27.68	14.74	1.80	1.80	0.36	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	30.21	10.24	1.66	1.45	0.52	0.52
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	22.80	11.40	2.05	0.46	0.00	0.46
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	44.05	15.10	8.81	0.84	0.00	0.42
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	33.92	11.96	2.24	1.05	0.45	0.45
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	33.61	10.07	1.75	0.88	0.44	0.61
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	40.13	17.67	1.10	2.58	0.37	0.74
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	40.35	17.74	1.14	0.29	1.14	1.14
mesenchymal stem cell line:Hu5/E18	10568-108B1	53.47	28.63	4.21	0.00	1.26	1.26
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	25.57	10.05	0.91	0.91	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	35.30	10.74	1.79	1.53	0.26	1.28
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	39.53	13.09	0.52	1.05	0.79	0.26
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	43.75	16.94	3.39	0.92	0.62	1.23
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	33.42	11.53	2.35	0.94	0.47	1.41
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	39.94	12.18	1.35	0.68	1.02	1.35
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	38.51	16.11	1.18	1.18	0.39	0.39
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	28.73	15.76	3.24	1.39	0.46	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	48.30	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	36.63	14.71	2.31	0.29	0.87	0.87
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	46.40	12.49	1.78	1.56	0.22	0.22
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	38.46	13.94	1.20	1.68	0.00	0.72
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	41.07	16.13	2.93	2.20	0.73	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	33.57	9.73	2.35	1.68	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	38.48	14.33	0.82	0.82	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	38.66	15.89	0.86	0.86	0.43	0.43
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	21.88	10.94	2.73	2.73	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	15.49	10.33	0.00	0.00	0.00	5.16
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	40.27	12.99	1.95	1.62	0.32	1.62
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	32.01	14.55	0.00	1.45	2.91	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	37.32	11.73	0.00	0.00	1.07	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	31.08	6.54	0.00	0.00	0.00	1.64
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	41.59	10.88	2.72	0.78	0.00	0.78
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	46.17	10.49	0.00	2.10	0.00	2.10
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	30.80	6.95	0.00	0.00	0.99	0.99
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	23.84	0.00	0.00	0.00	0.00	4.77
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	28.46	9.49	1.19	0.00	1.19	0.59
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	31.68	7.31	1.22	0.00	1.22	2.44
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	0.00	27.05	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	42.44	9.50	1.90	0.63	0.63	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	32.77	6.90	0.00	0.69	0.00	0.34
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	27.94	10.75	0.00	0.00	0.00	2.15
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	15.97	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	27.55	6.89	3.44	0.00	0.00	3.44
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	22.82	6.11	0.81	0.41	0.00	0.41
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	29.39	3.18	1.59	0.00	0.00	0.79
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	29.48	7.07	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	31.48	9.35	0.00	0.62	0.62	0.94
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	25.40	6.68	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	35.48	2.37	1.18	1.18	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	28.25	2.57	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	51.63	8.26	1.38	0.00	0.00	0.69
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	39.09	14.84	1.48	0.99	0.49	0.49
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	31.40	12.34	0.00	1.12	1.12	1.12
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	38.16	7.00	0.64	0.64	0.64	0.64
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	30.63	11.69	1.61	1.21	1.61	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	13.08	17.44	2.18	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	31.68	10.14	0.00	0.00	0.00	1.27
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	29.74	8.50	1.82	1.82	0.00	0.61
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	27.11	4.52	9.04	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	32.95	9.06	4.12	1.65	0.82	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	30.56	6.94	0.99	0.00	0.40	0.20
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	22.39	9.73	0.65	1.95	0.32	0.32
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	52.97	4.07	0.00	3.06	0.00	0.00
mesodermal tumor cell line:HIRS-BM	10696-109G3	81.24	46.42	0.77	1.55	1.55	0.00
mesothelioma cell line:ACC-MESO-1	10493-107B7	93.08	33.07	1.89	1.42	0.71	0.00
mesothelioma cell line:ACC-MESO-4	10494-107B8	96.84	31.74	6.26	2.55	1.39	0.46
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	85.47	29.92	8.55	0.00	0.00	0.00
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	39.15	14.39	2.57	0.41	0.92	0.72
mesothelioma cell line:Mero-25	10850-111F4	84.88	51.97	5.22	2.04	1.82	2.50
mesothelioma cell line:Mero-41	10851-111F5	75.30	29.09	6.36	1.71	1.47	0.73
mesothelioma cell line:Mero-48a	10852-111F6	52.04	23.69	3.10	1.11	0.44	0.89
mesothelioma cell line:Mero-82	10853-111F7	82.26	24.70	4.20	1.31	2.63	0.53
mesothelioma cell line:Mero-83	10854-111F8	50.39	22.98	3.23	1.02	1.70	0.68
mesothelioma cell line:Mero-84	10855-111F9	59.15	13.14	3.29	0.25	0.76	1.01
mesothelioma cell line:Mero-95	10856-111G1	57.14	22.57	3.11	1.45	0.83	1.04
mesothelioma cell line:NCI-H2052	10847-111F1	71.73	36.11	2.98	1.82	4.14	2.48
mesothelioma cell line:NCI-H226	10846-111E9	64.98	9.95	3.80	0.72	2.17	1.27
mesothelioma cell line:NCI-H2452	10848-111F2	56.54	19.47	2.90	1.71	1.02	0.68
mesothelioma cell line:NCI-H28	10845-111E8	49.37	34.86	2.04	3.56	2.04	1.53
mesothelioma cell line:No36	10857-111G2	45.02	28.71	1.96	2.61	2.28	0.00
mesothelioma cell line:ONE58	10858-111G3	67.74	29.26	4.06	1.08	2.98	1.35
migratory langerhans cells, donor1	11901-125F2	76.00	66.98	4.22	7.68	1.73	0.96
migratory langerhans cells, donor2	11902-125F3	82.55	60.33	3.05	5.13	1.47	0.49
migratory langerhans cells, donor3	11903-125F4	70.18	56.54	1.26	6.64	0.18	0.90
mixed mullerian tumor cell line:HTMMT	10689-109F5	64.64	28.73	2.61	1.31	0.33	2.61
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	57.22	7.42	2.33	0.00	0.64	1.27
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	130.61	29.03	5.53	0.69	2.76	0.00
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	69.27	16.75	4.00	0.76	1.52	0.19
myelodysplastic syndrome cell line:SKM-1	10772-110F7	111.98	70.96	2.40	2.77	2.77	2.22
myeloma cell line:PCM6	10474-106I6	97.05	23.52	4.55	1.19	0.20	0.59
myxofibrosarcoma cell line:MFH-ino	10600-108E6	152.19	20.29	8.62	2.03	1.52	0.00
myxofibrosarcoma cell line:NMFH-1	10684-109E9	57.27	34.91	1.96	1.57	0.39	0.59
nasal epithelial cells, donor1, tech_rep1	12226-129F3	27.41	34.54	0.78	2.90	0.45	0.45
nasal epithelial cells, donor1, tech_rep2	12226-129F3	23.09	36.92	0.66	2.79	0.22	0.29
nasal epithelial cells, donor2	12227-129F4	98.81	22.08	2.76	1.10	0.00	0.00
neuroblastoma cell line:CHP-134	10508-107D4	367.18	53.60	4.37	5.06	2.07	0.69
neuroblastoma cell line:NB-1	10539-107G8	138.07	52.38	4.12	4.68	0.94	0.94
neuroblastoma cell line:NBsusSR	10607-108F4	94.69	68.33	2.74	2.74	1.27	0.84
neuroblastoma cell line:NH-12	10555-107I6	204.80	92.43	2.80	6.71	2.42	1.49
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	106.99	110.78	3.08	10.20	0.95	3.08
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	112.77	149.04	4.75	7.29	2.38	1.90
neuroectodermal tumor cell line:TASK1	10774-110F9	129.61	36.83	4.23	3.42	0.60	1.01
neuroepithelioma cell line:SK-N-MC	10728-110A8	214.89	29.88	4.45	1.91	1.27	0.64
neurofibroma cell line:Hs 53.T	10729-110A9	58.56	18.63	2.93	1.33	0.53	0.27
neutrophil PMN, donor1	12133-128D9	2469.22	223.12	14.87	59.50	0.00	0.00
neutrophil PMN, donor2	12137-128E4	92.96	252.33	0.00	13.28	13.28	0.00
neutrophil PMN, donor3	12141-128E8	151.53	142.06	18.94	9.47	0.00	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	249.79	98.43	3.04	4.23	1.18	1.35
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	70.44	21.61	2.40	2.40	0.80	0.00
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	48.09	15.07	1.60	0.64	0.32	0.32
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	35.21	21.81	2.10	1.84	0.79	1.05
nucleus accumbens, adult, pool1	10037-101F1	108.36	80.62	7.41	4.03	8.16	0.94
occipital cortex - adult, donor10196	10172-103C1	63.87	43.27	6.18	0.00	4.12	2.06
occipital cortex, adult, donor10252	10163-103B1	119.42	116.74	4.29	2.42	6.44	0.81
occipital cortex, newborn, donor10223	10355-105E4	67.69	59.32	3.64	2.55	4.00	0.73
occipital lobe, adult, donor1	10076-102A4	84.23	55.89	10.50	2.89	4.99	0.26
occipital lobe, fetal, donor1	10073-102A1	129.59	103.41	8.58	5.15	6.44	0.43
occipital pole, adult, pool1	10036-101E9	108.25	73.01	10.25	2.37	6.15	0.63
olfactory region, adult	10195-103E6	69.54	63.43	8.60	2.67	5.35	1.15
optic nerve, donor1	10277-104E7	112.06	112.06	2.00	6.00	2.00	0.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	71.08	73.70	4.21	3.30	0.68	0.57
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	146.32	79.41	1.65	3.30	0.27	0.55
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	73.15	43.52	2.03	0.68	1.02	2.20
oral squamous cell carcinoma cell line:SAS	10544-107H4	145.43	35.92	6.12	0.92	3.93	2.77
osteoclastoma cell line:Hs 706.T	10704-109H2	42.63	32.34	1.76	1.18	0.29	0.00
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	270.96	31.77	3.74	0.93	1.87	0.00
osteosarcoma cell line:HS-Os-1	10558-107I9	87.37	36.26	2.33	1.48	0.85	0.42
ovary, adult, pool1	10020-101D2	89.88	137.93	2.10	7.42	0.35	0.61
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	50.05	13.57	2.57	0.37	0.55	0.37
pancreas, adult, donor1	10049-101G4	68.67	49.85	3.76	2.82	0.00	0.94
pancreatic carcinoma cell line:NOR-P1	10698-109G5	95.88	54.23	3.07	5.59	0.28	0.28
papillary adenocarcinoma cell line:8505C	10437-106E5	69.84	42.76	4.26	1.19	1.02	2.21
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	86.60	77.49	2.32	3.15	0.66	0.66
paracentral gyrus, adult, pool1	10035-101E8	92.07	64.98	8.60	2.65	7.32	0.92
parietal cortex, adult, donor10258	10373-105G4	60.19	56.52	5.14	1.47	6.61	1.47
parietal lobe - adult, donor10196	10171-103B9	56.43	36.68	6.58	0.94	0.94	0.94
parietal lobe, adult, donor10252	10157-103A4	86.37	77.24	6.84	3.71	5.70	0.00
parietal lobe, adult, pool1	10034-101E7	104.42	70.85	8.20	3.88	5.46	0.53
parietal lobe, fetal, donor1	10072-101I9	124.14	122.20	1.94	8.73	4.85	4.85
parietal lobe, newborn, donor10223	10356-105E5	64.68	61.69	6.36	1.87	5.23	0.75
parotid gland, adult	10199-103F1	93.12	72.15	5.55	3.70	3.08	0.62
penis, adult	10200-103F2	89.70	69.29	5.37	8.06	1.07	2.15
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	117.33	121.42	3.35	9.85	1.30	1.67
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	94.70	26.66	4.81	2.33	1.60	0.73
pineal gland - adult, donor10196	10179-103C8	70.31	87.08	9.03	5.81	2.58	0.00
pineal gland, adult, donor10252	10160-103A7	113.11	182.40	7.11	3.55	1.18	0.59
pineal gland, adult, donor10258	10377-105G8	104.72	71.49	6.27	4.39	2.51	0.00
pituitary gland - adult, donor10196	10180-103C9	50.59	123.44	3.04	0.00	0.00	1.01
pituitary gland, adult, donor10252	10162-103A9	119.35	257.46	3.13	13.55	2.08	2.61
pituitary gland, adult, donor10258	10378-105G9	52.78	95.34	1.70	8.51	0.00	0.00
placenta, adult, pool1	10021-101D3	76.97	57.62	2.04	3.44	0.54	0.54
plasma cell leukemia cell line:ARH-77	10840-111E3	102.50	24.76	5.69	1.46	1.46	2.25
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	52.14	30.51	1.71	1.09	0.47	0.62
pons, adult, pool1	10033-101E6	87.62	57.75	8.26	3.10	4.05	0.26
postcentral gyrus, adult, pool1	10032-101E5	102.43	74.27	11.25	2.35	6.54	0.52
promyelocytes/myelocytes PMC, donor1	12132-128D8	1179.55	87.84	10.46	2.09	6.27	2.09
promyelocytes/myelocytes PMC, donor2	12136-128E3	33.05	16.52	0.00	5.51	0.00	0.00
promyelocytes/myelocytes PMC, donor3	12140-128E7	93.89	11.74	0.00	0.00	0.00	0.00
prostate cancer cell line:DU145	10490-107B4	79.39	10.78	3.50	0.58	1.17	1.46
prostate cancer cell line:PC-3	10439-106E7	114.16	60.44	3.45	2.18	1.63	1.27
prostate, adult, pool1	10022-101D4	100.94	89.51	1.81	6.08	0.18	0.54
putamen, adult, donor10196	10176-103C5	100.80	58.54	8.03	3.54	7.79	1.89
putamen, adult, donor10252	10152-102I8	62.74	76.47	11.76	0.00	3.92	0.00
putamen, adult, donor10258, tech_rep1	10372-105G3	54.64	36.06	2.19	4.37	1.09	2.19
putamen, adult, donor10258, tech_rep2	10372-105G3	73.93	33.83	11.36	3.38	8.70	0.72
putamen, newborn, donor10223	10365-105F5	32.99	116.20	2.25	5.25	3.00	0.75
rectal cancer cell line:TT1TKB	10469-106I1	162.92	77.68	3.78	4.07	2.62	0.00
rectum, fetal, donor1	10067-101I4	151.62	37.56	5.56	2.78	0.00	0.00
renal cell carcinoma cell line:OS-RC-2	10411-106B6	48.12	22.90	2.76	1.48	1.27	0.21
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	42.66	31.07	0.41	1.66	1.24	0.83
retina, adult, pool1	10030-101E3	119.58	132.80	6.16	7.45	1.99	1.39
retinoblastoma cell line:Y79	10475-106I7	167.31	53.00	3.90	4.94	0.52	1.04
rhabdomyosarcoma cell line:KYM-1	10787-110H4	152.58	18.93	10.57	0.86	4.43	0.37
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	410.83	55.68	9.00	6.19	1.69	1.12
sacrococcigeal teratoma cell line:HTST	10695-109G2	112.92	24.25	1.52	1.52	0.76	0.00
salivary acinar cells, donor1	11771-123I7	75.10	25.74	4.53	2.91	1.13	0.32
salivary acinar cells, donor2	11772-123I8	72.97	18.31	3.30	2.48	2.48	0.96
salivary acinar cells, donor3	11773-123I9	138.37	31.12	7.28	1.32	1.99	0.00
salivary gland, adult, pool1	10093-102C3	73.21	50.90	6.29	5.72	1.72	1.14
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	72.42	15.60	3.46	1.52	1.60	0.34
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	61.60	13.17	3.76	0.24	1.29	0.35
seminal vesicle, adult	10201-103F3	139.15	99.99	5.29	9.52	4.76	5.29
serous adenocarcinoma cell line:JHOS-2	10639-108I9	67.29	65.59	2.67	2.67	3.16	0.73
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	44.04	30.20	1.26	1.76	1.01	0.50
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	59.21	18.06	2.01	1.00	1.00	2.01
serous cystadenocarcinoma cell line:HTOA	10693-109F9	60.18	78.58	2.69	4.70	0.81	1.21
signet ring carcinoma cell line:Kato III	10436-106E4	96.71	43.66	4.97	0.88	2.65	0.33
signet ring carcinoma cell line:NUGC-4	10483-107A6	90.06	25.55	4.77	1.16	2.06	0.39
skeletal muscle - soleus muscle, donor1	10282-104F3	156.05	34.76	4.26	2.13	2.84	0.71
skeletal muscle, adult, pool1	10023-101D5	122.46	64.53	3.48	5.76	1.08	0.60
skeletal muscle, fetal, donor1	10066-101I3	109.55	46.23	3.02	2.01	0.00	2.01
skin, adult, donor1	10074-102A2	67.85	33.93	0.00	0.00	0.00	6.79
skin, fetal, donor1	10065-101I2	85.22	42.92	3.79	1.89	0.63	1.26
small cell cervical cancer cell line:HCSC-1	10800-110I8	114.06	31.02	2.00	1.00	3.34	0.33
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	109.38	194.80	3.78	5.04	1.89	1.89
small cell lung carcinoma cell line:DMS 144	10841-111E4	115.65	79.03	5.01	6.55	0.96	0.39
small cell lung carcinoma cell line:LK-2	10541-107H1	215.59	76.97	7.42	6.43	2.31	1.32
small cell lung carcinoma cell line:NCI-H82	10842-111E5	76.08	121.76	0.64	22.84	0.16	1.13
small cell lung carcinoma cell line:WA-hT	10562-108A4	163.66	37.26	8.93	0.65	3.70	1.74
small intestine, adult, pool1	10024-101D6	110.01	74.53	5.61	2.15	2.03	0.84
small intestine, fetal, donor1	10064-101I1	76.17	49.88	2.46	2.46	0.74	1.72
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	60.01	54.37	2.05	2.05	4.10	1.03
smooth muscle, adult, pool1	10048-101G3	102.87	58.67	3.88	1.81	1.03	0.78
somatostatinoma cell line:QGP-1	10781-110G7	105.87	44.76	4.56	1.61	1.88	0.54
spinal cord - adult, donor10196	10181-103D1	90.62	51.62	7.80	2.06	1.61	0.69
spinal cord, adult, donor10252	10159-103A6	89.11	85.95	2.76	2.76	0.79	0.79
spinal cord, adult, donor10258	10369-105F9	31.13	53.96	1.38	2.08	0.69	1.38
spinal cord, fetal, donor1	10056-101H2	112.82	48.18	4.88	0.61	1.22	1.22
spinal cord, newborn, donor10223	10359-105E8	84.04	125.36	2.76	3.67	0.46	0.92
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	65.27	16.43	2.24	1.49	0.60	0.60
spleen, adult, pool1	10025-101D7	101.98	69.38	3.74	2.64	0.55	0.66
spleen, fetal, pool1	10044-101F8	129.67	95.11	5.56	3.73	1.75	0.32
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	92.95	16.98	2.79	1.45	1.86	0.62
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	75.76	35.89	2.47	2.47	0.76	0.00
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	100.64	42.98	5.24	2.10	1.75	2.45
squamous cell carcinoma cell line:T3M-5	10616-108G4	93.04	69.19	5.86	3.91	3.52	0.00
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	80.59	99.84	2.70	4.84	2.03	1.01
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	62.27	36.43	1.27	1.27	0.42	2.97
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	110.84	16.08	5.50	1.27	1.27	0.85
stomach, fetal, donor1	10062-101H8	152.72	30.97	7.48	3.20	0.00	0.00
submaxillary gland, adult	10202-103F4	119.63	94.00	4.56	5.70	1.71	2.85
substantia nigra - adult, donor10196	10178-103C7	0.00	54.27	0.00	0.00	0.00	0.00
substantia nigra, adult, donor10252	10158-103A5	88.90	117.15	2.49	4.57	0.42	1.04
substantia nigra, adult, donor10258	10371-105G2	31.04	35.69	1.03	0.52	3.10	1.55
substantia nigra, newborn, donor10223	10358-105E7	76.31	90.44	3.53	2.12	1.41	2.12
synovial sarcoma cell line:HS-SY-II	10441-106E9	96.75	31.87	4.81	2.75	0.69	0.69
temporal lobe, adult, pool1	10031-101E4	110.96	81.21	7.71	2.71	6.61	0.68
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	119.66	154.56	9.26	7.12	4.27	2.85
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	93.62	172.30	3.52	13.63	3.96	1.76
tenocyte, donor1	11763-123H8	43.99	21.64	0.00	0.00	1.05	2.44
tenocyte, donor2	11765-123I1	36.62	19.08	0.76	2.29	0.38	0.76
tenocyte, donor3	11768-123I4	28.54	11.86	1.48	0.37	0.74	1.11
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	118.80	47.76	5.10	4.08	1.19	1.02
teratocarcinoma cell line:NCR-G1	10798-110I6	102.66	43.16	1.85	3.55	0.31	1.23
teratocarcinoma cell line:PA-1	10807-111A6	112.05	48.51	2.94	3.25	0.77	0.31
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	131.26	44.56	3.68	3.17	1.02	1.27
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	104.75	118.37	0.76	8.70	0.38	0.76
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	92.48	29.01	4.58	6.54	0.76	0.33
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	94.45	76.54	2.28	4.89	0.65	0.98
testis, adult, pool1	10026-101D8	114.03	74.19	19.54	10.52	14.07	1.29
testis, adult, pool2	10096-102C6	152.47	152.02	30.67	29.32	23.91	4.51
thalamus - adult, donor10196	10168-103B6	59.62	71.76	3.31	1.10	1.10	0.00
thalamus, adult, donor10252	10154-103A1	106.27	151.13	3.91	5.47	1.88	0.78
thalamus, adult, donor10258, tech_rep1	10370-105G1	32.33	60.05	6.16	3.08	0.00	1.54
thalamus, adult, donor10258, tech_rep2	10370-105G1	37.22	31.29	6.09	1.81	1.81	0.66
thalamus, newborn, donor10223	10366-105F6	33.94	48.90	2.88	0.58	4.03	0.00
throat, adult	10209-103G2	103.36	77.90	6.99	4.49	0.50	1.25
throat, fetal, donor1	10061-101H7	97.81	61.86	1.83	2.74	0.91	1.22
thymic carcinoma cell line:Ty-82	10803-111A2	145.07	53.86	6.36	2.19	2.58	1.99
thymus, adult, pool1	10027-101D9	165.92	180.54	4.97	7.65	2.68	1.69
thymus, fetal, pool1	10043-101F7	154.92	138.19	6.65	4.36	1.25	0.94
thyroid carcinoma cell line:KHM-5M	10776-110G2	69.27	28.32	3.86	2.79	1.60	0.80
thyroid carcinoma cell line:TCO-1	10783-110G9	135.22	29.75	6.71	1.96	1.82	0.84
thyroid, adult, pool1	10028-101E1	101.90	84.73	2.15	6.72	0.28	0.84
thyroid, fetal, donor1	10060-101H6	86.22	104.67	3.16	6.06	1.85	0.00
tongue epidermis (fungiform papillae), donor1	10288-104F9	172.46	33.88	9.24	0.00	3.08	0.00
tongue, adult	10203-103F5	70.94	41.17	4.42	2.79	0.47	1.40
tongue, fetal, donor1	10059-101H5	56.75	34.68	2.36	2.36	0.39	1.18
tonsil, adult, pool1	10047-101G2	172.30	101.68	8.31	4.41	3.61	1.00
trachea, adult, pool1	10029-101E2	80.65	75.75	2.70	4.91	1.23	0.33
trachea, fetal, donor1	10058-101H4	76.94	52.70	2.69	1.92	0.77	0.38
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	66.96	16.30	4.96	1.06	0.71	0.00
transitional-cell carcinoma cell line:5637	10418-106C4	121.88	81.76	4.05	3.14	0.91	0.61
transitional-cell carcinoma cell line:JMSU1	10492-107B6	130.68	40.27	2.98	2.66	0.31	1.25
tridermal teratoma cell line:HGRT	10694-109G1	178.84	19.03	7.61	0.00	1.90	0.00
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	62.05	27.26	3.39	1.10	1.10	0.25
umbilical cord, fetal, donor1	10057-101H3	56.34	45.90	2.09	4.17	2.09	2.09
uterus, adult, pool1	10100-102D1	105.11	90.09	3.41	7.00	0.68	0.34
uterus, fetal, donor1	10055-101H1	105.46	40.95	3.07	1.02	0.00	0.51
vagina, adult	10204-103F6	102.75	116.32	1.29	2.58	0.00	2.58
vein, adult	10191-103E2	119.90	90.31	5.26	3.07	1.97	2.41
xeroderma pigentosum b cell line:XPL 17	10563-108A5	52.61	13.62	2.67	0.27	0.53	0.53

Property "Nearest transcripts" (as page type) with input value "BC038446:11 ENST00000482693.1:-18 ENST00000413951.5:-21 ENST00000681407.1:-35 Y08765:40 BC008080:-54 BC008724:-54 ENST00000377390.8:-56 ENST00000633899.1:-56 NM_001378957.1:-56 NM_001378956.1:-56 NM_001178030.2:-56 NM_201997.3:-56 NM_004630.4:-56 NM_201995.3:-56 NM_201998.3:-56 NM_001346363.2:-56 NM_001346364.2:-56 NM_001346410.2:-56 NM_001346409.2:-56 AK299705:-56 AK296237:-56 AB489174:78 EU832634:80 EU832710:80 CU675923:81 KJ892395:81 Y08766:-187 L49345:-244 L49380:-244 BC032676:-248 BC020217:-257 ENST00000227503.13:-261 ENST00000377394.7:-261 ENST00000448404.5:-261 BC069273:-261 ENST00000463343.1:-277 D26120:-277 D26121:-277 BC034451:-283 AK301803:-283 LF211197:-293 MA446774:-293 ENST00000334944.9:-300 ENST00000472725.5:437" contains invalid characters or is incomplete and therefore can cause unexpected results during a query or annotation process.